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Abstract 
The presence of emerging compounds in the environment is a worldwide concern, 
not only because of the potential negative impact in human health, but also due to the 
potential toxicity to non-target organisms. The Personal and Care Products (PCPs) are 
referred as emerging pollutants since they encompass a major class of compounds 
detected in the waters, with limited available information on their environmental impact. 
Within the PCPs class, the disinfectant triclosan (TCS) is one of the most concerning 
compounds. TCS is an antimicrobial used in many products of our daily life such as 
toothpastes, shampoos, deodorants or skin care products. It is produced to kill bacteria by 
blocking the fatty acid synthesis, inhibiting the cell growth. It is a photodegradable 
compound originating several by-products once in the water systems. One of its 
metabolites, methyl-triclosan (M-TCS), is known to bioaccumulate and to be resistant to 
photodegradation. M-TCS has been reported in the aquatic environments, although the 
information on its (eco)toxicity and mode of action is scarce.  
Perfluorinated compounds (PFCs) are another class of emerging chemicals and 
include de perfluoroalkyls acids (PFAAs) which have been extensively used in the chemical 
industry. Although some of PFAAs have been banned, i.e., perfluorooctane sulfonate 
(PFOS) and perfluorooctanoic acid (PFOA), several other homologues have been produced 
to substitute the formers, i.e., perfluorobutane sulfonate (PFBS) and perfluorobutanoic acid 
(PFBA). Most of these PFCs are extremely resistant to degradation, accumulating in the 
organisms and so, there is the need to improve ecotoxicological data. 
 In this work we aimed to improve the ecotoxicological data of TCS and its metabolite 
M-TCS and also of several selected PFAAs, i.e, PFOS, PFOA, PFBS, PFBS, PFDA and 
PFUnA using sea urchin (Paracentrotus lividus) and zebrafish (Danio rerio) embryos as 
models for ecotoxicity assessment. We performed bioassays with embryos for 144 hpf 
(hours-post-fertilization) for zebrafish (early larva) and 48h for sea urchin (larva pluteus 
stage).  
Our results point to an impact of both chemicals TCS and M-TCS, i.e., an increase in 
the abnormalities rates in zebrafish embryos and impact in the development of sea urchin 
larvae with a NOEC of 40 µg/L and <1.024 µg/L, respectively. PFAAs revealed low toxicity 
for zebrafish, however, apart from PFBA, all of the PFAAs tested delayed sea urchin larvae 
development at 1000 µg/L, and PFOS and PFOA affected the larvae development at 
concentrations of environmental relevance. Given the almost absence of ecotoxicological 
data on M-TCS and several PFAAs to marine invertebrates, the results present here are 
    2 
  
key to improve risk assessment of these chemicals. Further investigation should focus on 
the effects of chronic exposures and impacted molecular and biochemical pathways.  
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Resumo 
A presença de compostos emergentes no ambiente é um problema a nível mundial, 
não só por causa do impacto negativo na saúde humana, mas também devido à potencial 
toxicidade em organismos não-alvo. Os produtos de uso pessoal são referidos como 
poluentes emergentes já que englobam uma enorme classe de compostos detetados nas 
águas, para os quais a informação sobre o possível impacto ambiental ainda é limitada. 
Dentro da classe dos produtos de uso pessoal, o desinfetante triclosan é um dos compostos 
mais alarmantes. O triclosan (TCS) é um antimicrobiano usado nos mais variados produtos 
do quotidiano, como as pastas de dentes, shampoos, desodorizantes ou cremes para 
cuidados da pele. Este composto é produzido para eliminar bactérias, e a sua função é 
bloquear a síntese de ácidos gordos, inibindo assim o crescimento da célula. Este 
composto é fotodegradável e uma vez na água pode originar vários subprodutos. Um 
desses metabolitos, metil-triclosan (M-TCS), é conhecido pela sua capacidade de 
bioacumulação e resistência à fotodegradação e embora tenha sido detetado nas águas, 
a informação sobre a sua toxicidade e modo de ação é escassa.  
Os compostos perfluorados (PFCs) são outra classe de compostos emergentes, 
que incluem os ácidos perfluoroalquilos (PFAAs) que têm sido vastamente usados na 
indústria química. Embora alguns destes compostos tenham sido banidos, como é o caso 
do ácido perfluorooctano sulfónico (PFOS) e do ácido perfluorooctanoico (PFOA), outros 
compostos homólogos têm sido produzidos com o intuito de substituir os anteriores, como 
o ácido perfluorobutano sulfónico (PFBS) e o ácido perfluorobutanoico (PFBA). Grande 
parte destes compostos perfluorados são extremamente resistentes à degradação, 
acumulando-se nos organismos e por esse motivo, tem-se verificado uma grande 
necessidade em melhorar a informação ecotoxicológica destes compostos. 
Neste trabalho teve-se como principal objetivo contribuir para a avaliação 
ecotoxicológica do triclosan, do seu metabolito, metil-triclosan e ainda de vários compostos 
perfluorados que foram selecionados, como o PFOS, PFOA, PFBS, PFBA, PFDA e o 
PFUnA, usando embriões de ouriço-do-mar (Paracentrotus lividus) e de peixe-zebra (Danio 
rerio) como modelos de avaliação ecotoxicológica. Realizaram-se ensaios com embriões 
de peixe-zebra até 144 horas pós fertilização (estádio larvar) e até 48 horas pós fertilização 
para o ouriço-do-mar (estádio de larva pluteus). 
Os resultados apontam para um impacto do triclosan e do metil-triclosan na 
percentagem de anomalias do peixe-zebra e no desenvolvimento da larva de ouriço-do-
mar, obtendo um NOEC de 40 µg/L e <1.024 µg/L, respetivamente. Os compostos 
perfluorados revelaram ser pouco tóxicos para o peixe-zebra, no entanto, excetuando o 
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PFBA, todos os PFAAs atrasaram o desenvolvimento da larva de ouriço-do-mar para a 
concentração de 1000 µg/L e tanto o PFOS como o PFOA, afetaram o desenvolvimento 
larvar a concentrações ambientalmente relevantes. Dado que a informação ecotoxicológica 
do metil-triclosan e de muitos PFAAs para invertebrados marinhos, é praticamente 
inexistente, os resultados obtidos neste estudo são chave para melhorar a avaliação de 
risco destes químicos. Posterior investigação deverá focar-se nos efeitos de exposições 
crónicas e o seu impacto nas vias de sinalização moleculares e bioquímicas. 
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1. Introduction 
1.1. Contaminants of emerging concern (CECs) in the environment 
Nowadays it is acknowledged that the Wastewater Treatment Plants (WWTP) 
stations are not fully efficient when it comes to the removal of compounds present in the 
waters. Hence, a large group of chemicals will ultimately reach the aquatic environment. 
Although most of these chemicals are present at low concentrations, there is a paucity of 
data on the effects of low exposure doses and mixture effects, thus sorting them as 
emerging contaminants. 
The term “emerging” is applied to compounds present in the waters on which very 
little is known about potential impact in the environment (Deblonde et al., 2011). Moreover, 
data on its toxicity and potential risk is scarce or still unknown. Such chemicals have been 
a worldwide concern, not only for human health but also for the ecosystems.  
  
1.1.1. Personal and care products: triclosan (TCS) and methyl-mriclosan (M-TCS) 
metabolite 
The so called Personal Care Products (PCPs) are one of the groups that raise major 
concerns since it encompasses a large number of compounds that are produced for 
external use. The increase use of PCPs together with the inefficiency of the WWTP stations 
to complete removal of some of these chemicals, has been rising the levels of these 
compounds in the environment. Hence, an increase number of studies focus on their 
occurrence in the water systems. Yet, there is a lack of knowledge about its toxicity to non-
target organisms (Brausch and Rand, 2011).  
This is the case for the disinfectant triclosan (TCS) (Figure 1) which has been in use 
for over 40 years (Dann and Hontela, 2011; Pintado-Herrera et al., 2014) in the most varied 
toiletries such as toothpaste, soaps, skin care products and also in many other industries 
as textile and plastic industries (Bedoux et al., 2012; Rüdel et al., 2013). 
  As reviewed in 2011 by Brauch and Rand, this disinfectant in one of the most 
detected compounds in the WWTP, although there is still a lack of data on possible effects 
in non-targeted organisms and the underlying mechanism(s) of action. Hence, there is a 
need to improve risk assessment of this compound. 
Triclosan is an antimicrobial agent, more specifically a bactericide, which has the 
ability of inhibiting the fatty acids synthesis in the lipid membrane, preventing the cell from 
growing (Russel, 2004). As it is produced to be released in its parental form, this compound 
usually do not suffers any metabolic alterations thus entering the environment, increasing 
the levels in the water stations and surface waters. Although the removal rate of TCS in the 
WWTPs is around 80% (Deblonde et al., 2011), it still has been detected in more than half 
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of the surface waters analyzed (Brausch and Rand, 2011) including in Portugal (Lygina et 
al., 2013). 
Triclosan is an organochlorine compound and due to its chemical properties, 
bioacumulates (Figure 1). Once entering the WWTP stations, triclosan can be chemically 
transformed, resulting mostly chlorophenols (Bedoux et al., 2012) or biologically 
transformed, being metabolized into a more persistent, lipophilic and non-photodegradable 
byproduct known as methyl-triclosan (M-TCS) (Figure 1) (Balmer et al., 2004; Heidler and 
Halden, 2007; Bedoux et al., 2012). As reviewed by Bedoux in 2012, M-TCS can be 
produced in major quantities when biodegradation of TCS occurs in soil.  
Regarding TCS and M-TCS occurrence in the water systems it is known that the 
metabolite is much less prevalent than the parental compound. While TCS concentrations 
in surface waters where detected up to 22 µg/L in treated water in Spain (Agüera et al., 
2003), or even more recently up to 5,16 µg/L in Vellar, India (Ramaswamy et al., 2011), M-
TCS has been detected up to 190 ng/L in Cadiz, Spain (Pintado-Herrera et al., 2014). 
Although its occurrence is much less noticed, its hydrophobic characteristics and 
persistence in the environment along with the scarcity of data, highlights the need for 
additional research on its ecotoxicity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 - Chemical structure of TCS and its methylation by-product M-TCS.  
Source: CSID:5363, http://www.chemspider.com/Chemical-Structure.5363.html (accessed 
21:58, May 11, 2015); CSID:545009, http://www.chemspider.com/Chemical-
Structure.545009.html (accessed 21:57, May 11, 2015).(1)Boehmer et al., 2004; (2)Ying et al., 
2007; (3)Chen et al., 2011. 
TCS 
C12H7Cl3O 
logKow: 4.7(1) 
VP: 4.65x10-6 mmHg(2) 
M-TCS 
C13H9Cl3O2 
logKow: 5.2(1) 
VP: 0.00093 Pa(3) 
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1.1.1.1. State of knowledge on triclosan and methyl-triclosan toxicity  
Many studies have been conducted in order to better understand the mechanism of 
action and the No Observed Effect Concentration (NOEC) of this bactericide. In 
Scenedesmus vacuolatus, triclosan inhibited cell reproduction at 1.9 µg/L (Franz et al., 
2008). A recent study with the sea urchin Strongylocentrotus nudus, showed that triclosan 
affected reproduction and embryonic development of pluteus larva at 113 µg/L (Hwang et 
al., 2014). On zebrafish, triclosan was lethal to 50% of the embryos at 420 µg/L (Oliveira et 
al., 2009) and significantly decreased heart rate of embryos at 20 ng/L and at 100 µg/L 
(Schmidt et al., 2013). Also in Japanese medaka, an 8 days exposure to triclosan at 
0.17mg/L, decreased the swimming velocity of the fish (Nassef et al., 2010). 
Gaume et al. (2012), in an in vivo study showed that not only TCS had an inhibiting 
effect on cells but also M-TCS reveled to be toxic to hemocytes of Haliotis tuberculata, at 
low concentration range. Other studies have been conducted on M-TCS toxicity on algae 
(Batscher, 2006b) and bacteria (Farré et al., 2008; Villa et al., 2014) and only one conducted 
on the invertebrate Daphnia magna (Batscher, 2006a). To our knowledge, no other studies 
have been reported on aquatic organisms. 
Taking all these data into account, there is the need for research on this subject, 
especially on M-TCS toxicity. Given the sensitivity of the embryonic development of model 
fish zebrafish (Danio rerio) and the invertebrate sea urchin (Paracentrotus lividus) to a range 
of contaminants, including TCS, make them ideal models to investigate the toxicity of TCS 
and M-TCS. 
 
1.1.2. Synthetic chemicals: perfluorinated compounds (PFCs) 
1.1.2.1. Background and applications 
Perfluorinated compounds (PFCs) are synthetic chemicals produced by 
electrochemical fluorination (ECF) or telomerization and have been used for over 60 years 
(Simcik, 2005; Lindstrom et al., 2011; Lau, 2012). They encompass a large number of 
chemicals useful in the most varied industries, mainly in textile industries where they are 
used as repellants for carpets or clothes (Ulhaq et al., 2013a). Moreover they can be used 
as surfactants and lubricants, in paints, fire-fighting foams, food packaging, floor polishes, 
in some products of personal care such as shampoos, cosmetics and also as pesticides, 
among many others (Lindstrom et al., 2011). 
Their great applicability has led to environment contamination of several aquatic 
ecosystems (Figure 2). Hence, in 2009 the Stockholm convention has listed some of these 
compounds such as Perfluorooctanesulfonic acid (PFOS) (Figure 4) and other derivatives 
in Annex B for Persistent Organic Pollutants (POPs), restricting the use of these chemicals 
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by 2010 and complete elimination by 2015 (US EPA, 2009). Given that in 2010 some PFCs 
were discontinued (Hagenaars et al., 2011), other homologues with shorter carbon chains 
have been used in large quantities as alternative and have been released to the 
environment. Although some studies revealed that these new homologues have low 
adsorption potential, they seem to be very persistent and more mobile than the original ones 
(Zhou et al., 2013).  
Non-target organisms are continuously exposed to these chemicals which are 
discharged in the waters through WWTPs (Ulhaq et al., 2013) (Figure 2). Very limited data 
is available concerning the potential impact of some of these new derivatives to the 
ecosystems and so it is urgent to deepen knowledge on this subject. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The PFCs class encompass a large number of sub-classes. Perfluoroalkyls acids 
(PFAAs) belong to the PFCs class and include about 30 environmentally relevant chemicals 
(Lau, 2012). There are 5 different subfamilies within the PFAAs, distinguished by their 
functional group which can be a carboxylic, sulfonic, phosphonic, sulfinic or phosphinic acid 
(Schedin, 2013).The main sub-families which have gained more attention are the 
Perfluoroalkyl sulfonates acids (PFSAs) and Perlfuoroalkyls carboxyls acids (PFCAs) and 
more recently the Perfluoroalkyls phosphonates acids (PFPAs) (Figure 3) (Lau et al., 2012).  
Production 
and usage 
of PFC 
products 
WWTPs 
Sludge 
Landfill 
River 
Soil 
Plants 
Aquatic animals 
Ocean 
Groundwater 
Land animals 
Sediment 
Air 
Humans 
Figure 2 - Environmental fate of Perfluorinated compounds. Adapted from Ahrens, 2011.  
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1.1.2.2. PFCs chemical properties  
Perfluorinated compounds are organic substances whose structure usually consists 
in a (4 - 14) carbon chain where all hydrogen molecules in the carbon chain were substituted 
with fluorines (Figure 4). They are extremely chemically stable due to their strong carbon-
fluorine bonds. Their distinctive hydrophobic and lipophobic properties allow them to repel 
oil and water (Lau et al., 2007). Also, they are nonflammable, non-reactive, and hardly 
degraded, possibly bioaccumulating and consequently persisting in the environment 
(Lindstrom et al., 2011). Furthermore, some of these substances have long-range transport 
in the waters due to their ionic nature (Sinclair and Kannan, 2006), and so, after discharges, 
the PFCs can easily reach rivers, soils, ground waters, oceans, and consequently affect the 
aquatic and land life, including humans (Figure 2). 
Figure 3 - Some examples of Perfluorinated compounds. In bold are the Perfluoroalkyls acids 
selected for the present work. 
 
 
PFCs/
PFAs
FASAs
PFAAs
PFCAs
PFOA
PFBA
PFUnA
PFDA
PFPAs
PFSAs
PFOS
PFBS
PFHxS
PFDS
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1.1.2.3. State of knowledge on the PFAAs selected for the present study 
         Perfluoroalkyls acids (PFAAs) is the main group responsible for studies conducted on 
Perfluorinated compounds distribution, occurrence or toxicity. They are extensively used, 
mostly due to their unique chemical properties.  
         They have been classified as chemicals of concern and after the decreased 
production of PFOA and PFOS, several other substitutes have been released in large 
quantities to the environment (Lau, 2012).  
        One of the main problems is the possibility of increased toxicity of these chemicals 
when in mixture. In 2002, after an accidental release of fire-fighting foam in Canada, the 
PFCs concentration in the surface waters reached up to 17mg/L (Moody et al., 2002). 
Moreover, in west coast of Korea in 2012, concentrations of several PFAAs from the 
estuarine and coastal area were detected up to 130 ng/L (Hong et al., 2015). In China, the 
total concentrations of PFAAS was measured, reaching values of 70.4 µg/L (Zhou et al., 
2013). 
        Some long-chained PFAAs (e.g. PFOS) have a high potential for bioaccumulation and 
biomagnification along the trophic chain (Kannan et al., 2005; Hong et al., 2015). 
Furthermore, PFAAs are usually extremely resistant to high temperatures, photolysis or 
even microorganisms, due to their strong fluorine-carbon chain (Schedin, 2013). Figure 5 
displays the perlfuoroalkyl compounds chemical formula. 
        Regarding their distribution, PFAAs are ubiquitous in the environment, being already 
found in some remote areas such as the Artic or in Antarctica (Butt et al., 2010; Benskin et 
al., 2012; Cai et al., 2012). Lau (2012) reviewed two possibilities for PFAAs worldwide 
distribution: atmospheric transport of PFAAs or simply a long-range transport of the PFAAs 
along the water systems, thus reaching isolated areas. 
Figure 4 - Perfluorooctane sulfonate (PFOS) chemical structure. 
Source: CSID:67068, http://www.chemspider.com/Chemical-
Structure.67068.html (accessed 12:04, May 20, 2015). (1)Higgins and 
Luthy, 2006; (2)3M, 2008c. 
 
 
 
  
PFOS 
C8HF17O3S 
logKoc: 2.57 ± 0.13 L/kg(1) 
VP: 2.48x10-6 mmHg(2) 
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1.1.2.3.1. Perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid 
(PFOA) 
Perfluorooctane sulfonate (PFOS) (Figure 4) and Perfluorooctanoic acid (PFOA) 
(Figure 6) are an 8 carbon long chained PFAAs, with a sulphonic and carboxylic acid as 
function group, respectively. In industry they were used mainly as byproducts of other 
fluorochemicals (Simcik, 2005). 
They gained much attention due to their useful characteristics and so, countless 
studies were conducted on their occurrence and toxicity. Regarding their occurrence in 
surface waters, before regulation, PFOA concentrations ranged from <25 to 598 ng/L while 
PFOS ranged from 16.8 to 144 ng/L in Tennessee (Hansen et al., 2002). In Japan, PFOA 
and PFOS concentrations reached up to 67000 and 526 ng/L, respectively (Nakayama et 
al. 2004). 
Although their producing has been reduced after regulation, their bioaccumulative 
and persistent properties still raise concern on its possible impact in the organisms. Houde 
et al. (2011) reviewed that PFOS was still the major PFC found in animal tissues. 
Furthermore, PFOS and PFOA were found in artic species tissues, evidencing their 
worldwide distribution (Butt et al., 2010).  
More recently, in Liaoning, China, concentrations up to 31 and 82 ng/l of PFOS and 
PFOA, respectively, where detected in surface waters (Wang et al., 2012).  Also, in Tangxun 
Lake, China, concentrations of PFOS and PFOA in surface waters of up to 21.3 and 26.3 
µg/L, respectively (Zhou et al., 2013).  
 
 
 
 
 
 
 
 
Figure 6 - Perfluorooctanoic acid (PFOA) chemical structure. 
Source: CSID:9180, http://www.chemspider.com/Chemical-Structure.9180.html 
(accessed 12:02, May 20, 2015). (1)Dekleva, 2003; (2)Bhhatarai and Gramatica, 
2010. 
  
PFOA 
C8HF15O2 
logKoc: 1.31-2.35 L/kg(1) 
VP: -1.04 mmHg(2) 
 
Figure 5 - Chemical formula of PFAAs.  n – number of carbon 
atoms; R- functional group. Schedin, 2013. 
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Regarding toxicity studies on these two chemicals, several studies have been 
conducted recently on zebrafish embryos (Shi et al., 2008; Huang et al., 2010; Hagenaars 
et al., 2011; Zheng et al., 2012; Ding et al., 2013; Ulhaq et al., 2013a,b; Hagenaars et al., 
2014). PFOS appears to be more toxic than PFOA possibly due to the presence of a 
sulphonic functional group (Zheng et al., 2012; Ulhaq et al., 2013a). Hagenaars et al. (2011) 
detected an increase in the fish heart rate above 0.5 mg/L for PFOS and above 75 mg/L for 
PFOA, with a significant decrease at 250 mg/L. Furthermore, PFOA significantly delayed 
hatching above 100 mg/L. In Zheng et al. (2012) study, PFOS Lowest Observed Effect 
Concentration (LOEC) for malformations on zebrafish embryos was established at 12.5 
mg/L and at 6.5 mg/L for hatching delay at 72 hpf.  
Moreover, PFOS along with perfluorobutane sulfonate (PFBS) and 
Perfluorodecanoic acid (PFDA) seemed to increase swimming speed of zebrafish larvae in 
comparison with other PFAAs (Ulhaq et al., 2013b). More recently, PFOS significantly 
reduced the swim bladder, caused spinal curvature and reduced zebrafish larvae length 
above 2.5 mg/L (Hagenaars et al., 2014). 
Concerning studies on invertebrates, PFOA exposure during 48h had an Effect 
Concentration on 50% of Daphnia magna and Chydorus sphaericus population (EC50) at 
211.6 and 348.7 mg/L, respectively (Ding et al., 2012).  
Sea urchin embryos have also been used as ecotoxicological models for studying 
the effects of some PFCs (Anselmo et al., 2011; Mhadhbi et al., 2012; Gunduz et al., 2013). 
Paracentrotus lividus seems to be relatively sensitive to these particular compounds, 
showing an increasing number of malformations on the larvae above 0.5 mg/L of PFOS 
(Gunduz et al., 2013) and a LOEC for PFOS and PFOA of 2 and 20 mg/L, respectively 
(Mhadhbi et al., 2012). Moreover, Anselmo et al., 2011 detected a slight acceleration on 
larvae development 9 days post-fertilization (dpf) at 371.6 µg/L. 
The fact that the potential for bioaccumulation of PFAAs in costal organisms has not 
been study in detail (Hong et al., 2015) along with the lack of data on the potential toxicity 
to marine species (Mhadhbi et al., 2012; Gunduz et al., 2013) make this subject of concern. 
All these previous studies were conducted with concentrations above environmental 
relevance. However, since these chemicals are extremely stable and not easily degraded 
in the environment (Lindstrom et al., 2011), they may bioaccumulate, hence it is urgent to 
understand their impact. Chronic exposure and biomagnification of these chemicals are of 
concern as well since they can potentially affect not only the organisms but possibly their 
offspring (Kannan et al., 2005).  
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1.1.2.3.2. Perfluorobutane sulfonate (PFBS) and perfluorobutanoic acid 
(PFBA) 
The short-chained perfluorobutane sulfonate (PFBS) and perfluorobutanoic acid 
(PFBA) have a skeleton constituted by 4 carbons and have been considered the main 
substitutes of PFOS and PFOA, respectively (Figure 7). Their toxicity seems to be much 
less noticed due to their short carbon chain length (Shi et al., 2008; Hagenaars et al., 2011; 
Zheng et al., 2012). Yet, due to their exponential production increase, they are much more 
prevalent than PFOS and PFOA (Zhou et al., 2013), although the information on their 
potential toxicity is not well established.  
In river Rhine the concentrations of PFCs were measured and PFBA was dominant, 
reaching concentrations up to 335 ng/L followed by PFBS at 181 ng/L (Möller et al., 2010). 
In China, concentration of PFBA and PFBS were prevailing, reaching up to 47.8 and 15.3 
µg/L, respectively (Zhou et al., 2013). 
Concerning toxicity assessment, it is known that these chemicals are not as toxic as 
the long-chained PFAAs. A study conducted on zebrafish embryos found an EC50 of 450 
mg/L and 2200 mg/L for PFBS and PFBA, respectively (Ulhaq et al., 2013a). Moreover, 
PFBS showed reduced zebrafish heart rate at 3000 mg/L (Hagenaars et al., 2011).  
In Daphnia magna the EC50 at 48h for PFBA was reached at a concentration of 181.5 
mg/L. As for Chydorus sphaericus, the EC50 value for PFBA was only reached at 462.3 
mg/L (Ding et al., 2012). 
PFBA and PFBS growing discharges in the environment along with their great 
mobility throughout the water systems is concerning. The fact that there is still a massive 
lack of data on the potential toxicity of these new substitutes on marine organisms makes 
urgent a detailed toxicity screening.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 - Perfluorobutane sulfonate (PFBS) and Perfluorobutanoic acid (PFBA) chemical structures. 
Sources: PFBS: CSID:61132, http://www.chemspider.com/Chemical-Structure.61132.html (accessed 
12:15, May 20, 2015). PFBA: http://www.chemspider.com/Chemical-Structure.9394.html (accessed 
12:14, May 20, 2015). (1)Wang et al., 2011; (2)Bhhatarai and Gramatica, 2010. 
 
PFBS 
C4HF9O3S 
logKow, dry: 2.82(1) 
VP: 2.80 Pa(1) 
PFBA 
C4HF7O2 
logKow,dry: 3.90(1) 
VP: 0.83 mmHg(2) 
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1.1.2.3.3. Perfluorodecanoic acid (PFDA) and perfluoroundecanoic acid 
(PFUnA)  
Perfluorodecanoic acid (PFDA) (Figure 8) and perfluoroundecanoic acid (PFUnA) 
(Figure 9) are a 10 and 11-carbon chain perfluorocarboxylates (PFCAs), respectively. They 
are widely used in manufacturing of fluorinated polymers (Prevedouros et al., 2006). 
Concerning their occurrence, it is known that these two PFAAs are much less prevalent in 
the waters in comparison with the previous four PFAAs. In Shenyan, China, PFUnA and 
PFDA were detected in Donghou River at 1.2 and 0.66 ng/L, respectively (Sun et al., 2011). 
Also in Touchien, Taiwan, PFDA was found in concentrations of up to 58.2 ng/L (Lin et al., 
2009). Furthermore, concentrations of up to 15.4 and 3.52 ng/L were detected in west coast 
of Korea for PFDA and PFUnA, correspondingly (Naile et al., 2010). Moreover, PFDA was 
found up to 160 ng/L in Conasauga River, USA (Knowick et al., 2008) and more recently up 
to 1.2 ng/L in Australia (Thompson et al., 2011).  
As mentioned before, Ding et al., 2012 assessed the toxicity of several 
Perfluorinated compounds on Dapnia magna and Chydorus sphaericus during 48h. In D. 
magna, a fifty percent inhibition effect at 163.5 mg/L for PFDA and 133.13 mg/L for PFUnA 
were reported. In Chydorus sphaericus, the fifty percent inhibition effect was detected at 
45.2 mg/L for PFDA and 19.2 mg/L for PFUnA. This compounds show greater toxicity in 
comparison with PFBS and PFBA, possibly due to their longer C-F chains. To our 
knowledge, this is the only study assessing PFUnA toxicity in aquatic organisms. 
As long-chained compounds, there is propensity to become more bioaccumulative 
in the organisms (Lindstrom et al., 2011). However, there is a massive lack when it comes 
to their potential impact in the environment (Jo et al., 2014). Some studies revealed that 
PFDA is in the range of PFOS toxicity (Ulhaq et al., 2013a). Yet, toxicity data on these two 
compounds is very limited. 
 
 
 
 
 
 
 
 
Figure 8 - Perfluorodecanoic acid (PFDA) chemical structure. 
Source: CSID:9181, http://www.chemspider.com/Chemical-
Structure.9181.html (accessed 12:10, May 20, 2015). (1)Higgins and 
Luthy, 2006; (2) Bhhatarai and Gramatica, 2010. 
 
PFDA 
C10HF19O2 
logKoc: 2.76 ± 0.11 L/kg(1) 
VP: -2.12 mmHg(2) 
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1.2. Aim of the study 
In the present study we aimed to improve ecotoxicological information of several 
emerging contaminants on which available data is scarce. The selected compounds were 
the disinfectant triclosan and its metabolite methyl-Triclosan and also 6 perfluoroalkyls acids 
such as perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA), perfluorobutane 
sulfonate (PFBS), perfluorobutanoic acid (PFBA), perfluorodecanoic acid (PFDA) and 
perfluoroundecanoic acid (PFUnA). To achieve this goal, the well validated embryo 
development bioassays with zebrafish (Danio rerio) and sea urchin (Paracentrotus lividus) 
embryos were conducted. 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 – Perfluoroundecanoic acid (PFUnA) chemical structure. 
Source: CSID:69649, http://www.chemspider.com/Chemical-Structure.69649.html 
(accessed 12:08, May 20, 2015). (1)Higgins and Luthy, 2006; (2)Kaiser et al., 2005. 
 
PFUnA 
C11HF21O2 
logKoc: 3.30 ± 0.11 L/kg(1) 
VP: –0.98(2) 
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2. Materials and Methods 
2.1. Tested chemicals  
The chemicals tested in this study were obtained from Sigma-Aldrich Company 
(Table 1). All stock solutions were prepared in Dimethylsulfoxide (DMSO) obtained from 
Merck. 
    Table 1 – References of the chemicals tested. 
 
2.2. Artificial seawater 
The artificial water was prepared according to Zaroogian et al. (1969) (Table 2). 
Sodium chloride and Sodium bicarbonate were both obtained from Merck, whereas 
Magnesium sulfate, Magnesium chloride hexahydrate and Calcium chloride were all 
obtained from Sigma-Aldrich. 
 
   Table 2 - Artificial seawater composition. Source: Zaroogian  et al., 1969 
 
 
Abbreviation Name CAS number 
TCS Triclosan 3380-34-5 
M-TCS Methyl-triclosan 4640-01-1 
PFOS Perfluorooctanesulfonic acid 2795-39-3 
PFOA Perfluorooctanoic acid 335-67-1 
PFBS Perfluorobutanesulfonic acid 375-73-5 
PFBA Perfluorobutanoic acid 375-22-4 
PFDA Perfluorodecanoic acid 335-76-2 
PFUnA Perfluoroundecanoic acid 2058-94-8 
Molecular formula Name CAS number 
NaCl Sodium chloride 7647-14-5 
NaHCO3 Sodium bicarbonate 144-55-8 
MgSO4 Magnesium sulfate 7487-88-9 
MgCl2·6H2O Magnesium chloride hexahydrate 7791-18-6 
CaCl2 Calcium chloride 10043-52-4 
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2.3. Test organisms 
2.3.1. Sea urchin (Paracentrotus lividus) 
Paracentrotus lividus is a benthic invertebrate, very common in the Mediterranean 
Sea (Tomas et al., 2004) and eastern Atlantic (Boudouresque and Verlaque, 2013; Jacinto 
et al., 2013). They usually live in seas ranging temperatures from 10-15ºC in winter to 18-
25ºC in the summer (Boudouresque and Verlaque, 2013). In the adult stage they can reach 
about 7 cm of diameter (Boudouresque and Verlaque, 2013) (Figure 10). 
Regarding reproduction, these organisms have a specific timing on gonadal growth, 
occurring once a year. It is stimulated by the photoperiod and the rising of temperature 
during the summer, usually between May and September (Byrne, 1990). 
There is a growing economical relevance of this species in Europe. Furthermore it 
plays a very important ecologic role in preserving the balance of the ecosystems (Tomas et 
al., 2004). 
Toxicity assessment on sea urchin embryonic development as become very 
important since these organisms seem to be very sensitive to several classes of chemicals 
(Pinsino et al., 2010; Hwang et al., 2014; Ribeiro et al., 2015). Furthermore, toxicological 
assays in this species are advantageous because of their short embryonic development. It 
takes 48h to reach larva pluteus stage (Ribeiro et al., 2015), allowing to perform a large 
number of assays in a short period of time and limited space facilities. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 - Sea urchin (Paracentrotus lividus). 
Source: Pixabay Database. 
Available on: https://pixabay.com/pt/ouri%C3%A7o-do-mar-
animal-natureza-597313/. 
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In our study, the organisms were all collected in intertidal areas in the Northem 
Portugal, Vila Nova de Gaia, Granja (N41º 2’ 26,18’’, W -8º 39’ 2,24’’) and transported to 
the laboratory in a refrigerator container. 
Sea urchin reproduction was stimulated in vitro following Ribeiro et al., 2015 
protocol. The organisms were dissected and the gametes evaluation was performed on a 
Nikon eclipse 50i microscope, selecting the female and male based on their eggs quality 
and sperm mobility, respectively. A viable couple was selected for each assay (Figure 11 
A). 
A considerable concentration of eggs was collected from the female and placed on 
100 mL of artificial salt water and some sperm was added to the mixture. After slowly 
shaking to help fertilization success, it was determined the fertilization rate calculating the 
number of fertilized eggs in three drops of 10 µL of solution which is recognized by the 
appearance of an external membrane (Figure 11 B). The eggs were randomly distributed in 
the plate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.1.1. Experimental design 
Initially, two pairs of concentrations with a 2.5x dilution factor were tested (1000, 400 
and 100, 40 µg/L) in order to cover a wide range of concentrations. Based on the results of 
the first assay, four additional concentrations (2.5x diluted from the 40 µg/L concentration) 
were tested in order to test environmentally relevant concentrations. Hence, we exposed 
sea urchin to eight different concentrations for each chemical: 1000; 400; 100; 40; 16; 6.4; 
2.56 and 1.024 µg/L. All stock solutions were dissolved in Dimethylsulfoxide (DMSO) CAS 
number 2206-27-1 in order to obtain a final DMSO concentration of 0.01%. Finally the 
solutions were stored at 4°C.  
100 µm 
Figure 11 - (A) Sea urchin adults dissected (male and female, respectively). (B) Sea urchin 
eggs post fertilization (the arrow points to a non-fertilized egg). 
 
B A 
    38 
  
The fertilized eggs were incubated for 48h in the dark at 20ºC in 24-well plates with 
a concentration of 20 eggs/mL/well. Overall, four independent replicate plates were run for 
each chemical, i.e., 16 replicates for control and solvent control and 8 replicates for each 
treatment (Figure 12). LOEC (Lowest Observed Effect Concentration) and NOEC (No 
Observed Effect Concentration) were determined. 
Embryo observations were conducted in a Nikon Eclipse 5100T inverted microscope 
equipped with a Nikon D5-Fi2 digital camera. Randomly, fifteen larvae per well were 
observed two days after fertilization in the pluteus phase following previous protocols 
(Ribeiro et al., 2015). The endpoints determined were larval abnormalities and the 
maximum larvae length which was measured by NIS-Elements version 4.13 image 
acquisition software. 
 
 
 
 
 
 
 
 
 
  
 
2.3.2. Zebrafish (Danio rerio) 
Zebrafish (Danio rerio) is a well-known vertebrate tropical fish. It is native from Asia 
and usually dwells in streams (Engeszer et al., 2007) (Figure 13). In spawning conditions, 
the adults move into muddy and vegetated areas with stagnant waters to release the eggs 
(Engeszer et al., 2007).  When mature, the female and male are easily distinguished by the 
prominent abdomen of the female. 
It has been used for the past two decades as model species in different areas of 
research. Apart from being cost-effective, the adults are easily obtained and maintained in 
laboratory conditions. Furthermore, the adults can breed all year around, producing a large 
number of eggs per spawning, 200-300 per couple (Hill et al., 2005). The short embryonic 
development is also useful, 72h to reach early larva stage (Kimmel et al., 1995), allowing to 
Figure 12 - Experimental design for sea urchin bioassay. C – Control; C+S 
– Solvent Control; T – Treatment. 
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perform several toxicity assays in a short period of time. In addition, the small size and 
transparency of the eggs enables the incubation in microplates and the observations of 
possible phenotypic changes through the embryos chorion, being easily manipulated 
(Segner et al., 2009). All these benefits make this species ideal for an acute toxicity assay.  
 
 
 
 
 
 
 
 
 
 
 
 
 
The zebrafish stock was obtained from local suppliers in Singapure and kept in 
laboratory in a 160L aquarium with dechlorinated water at 28ºC ± 1, pH 8.0 ± 0.5 with a 
system of recirculation and water renewal passing through mechanical and biological filters. 
The fish were maintained with a photoperiod of 14/10h (light/dark).The stock was fed with 
TetraMin® feed four times daily by an automatic feeder and supplemented with Artemia. 
For the zebrafish reproduction, 5 females and 10 males, were isolated in a breeding 
box the day before reproduction. It has been described that zebrafish females prefer gravel 
substrates to spawn, producing higher quality eggs (Spence et al., 2007). Therefore, the 
breading box contained marbles with a net bellow, thus mimicking the gravel substrate 
(Figure 14). Furthermore, the marbles with the net allowed the eggs to pass and settle in 
the bottom of the aquarium, thus preventing the adults to reach the eggs, avoiding acts of 
cannibalism typical of this species. 
 In the following day the eggs were collected and cleaned one hour and a half after 
the light switch on. The eggs’ quality was verified through a magnifier and fertilized eggs 
were selected for the assay and distributed in the microplates within three hours after 
fertilization. 
 
 
 
 
Figure 13 – Zebrafish (Danio rerio).  
Source: Wikimedia Commons repository.  
Available on: https://commons.wikimedia.org/wiki/File:Zebrafisch.jpg. 
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2.3.2.1. Experimental design 
For zebrafish exposure assays to PFAAs we selected four concentrations, 10000, 
1000, 100 and 10 µg/L. These values were chosen based in the literature (Ulhaq et al., 
2013a) following a similar rational to that previously described for sea urchin assay. Only 
for triclosan the concentrations tested were different: 1000,100, 10 and 1 µg/L and then 
dilutions of 2.5 times were also performed to refine NOEC and LOEC (Oliveira et al., 2009). 
Finally, due to the limited number of toxicity studies performed on methyl-triclosan we chose 
to perform 10x dilutions as in the PFAAs assays and then dilutions of 2.5 times as in TCS 
assay to refine NOEC.  
The eggs were distributed into 24-well plate (10 eggs per well) and 16 replicates for 
each treatment were performed (Figure 15). The embryos were incubated at 26.5ºC ± 1 for 
144h (6 days) and the mediums were renewed every day in order to maintain the oxygen 
conditions, ensuring the compounds’ presence and mortality assessment. Observations 
were conducted at 8h, 32h, 80h and 144h (Figure 16), following previous protocols  (Ulhaq 
et al., 2013a; Hagenaars et al ., 2011; Zheng et al., 2012; Ribeiro et al., 2015). Several 
endpoints were determined, i.e., abnormal cell growth at 8hpf, embryo development delay 
at 32 hpf, abnormalities in the eyes, head, tail and yolk-sac, edemas and heart rate at 32, 
80 and 144hpf, hatching rate at 80hpf and mortality rate at 8hpf, 32, 80 and 144hpf. 
 
 
 
Figure 14 – Representation of zebrafish breading box. 
The blue arrow points the location of the eggs. 
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Figure 15 – Experimental design for zebrafish bioassay. C – Control; C+S – 
Solvent Control; T – Treatment. 
A 
B 
C D 
Figure 16 – Zebrafish embryonic development. A – 8 hpf (75% epiboly 
stage); B – 32 hpf (pharyngula stage); C, D – 80, 144 hpf (early larva 
stage). 
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2.4. Statistical Analysis  
All data was analyzed in SPSS Statistics software version 22.0.  Homogeneity of 
variances and normality of data were performed using Levene’s and Kolmogorov-Smirnov 
test, respectively. Significant differences among treatments were tested at the end of each 
assay (at 144 hpf for D. rerio assay, and 48 hpf for P. lividus assay) by means of One-Way 
ANOVA., considering significant differences when p<0.05. Then, comparisons between 
control groups and treatments were done using Student-Newman-Keuls multiple 
comparison test. Moreover, non-parametrical Krustal-Wallis test were also performed to 
multiple comparisons among individual treatments when homogeneity and normality were 
not achieved, even after data transformation.  
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3. Results  
3.1. Triclosan (TCS) 
3.1.1. Zebrafish embryos bioassay 
3.1.1.1. Cumulative mortality  
Two different embryo bioassays with zebrafish were performed upon exposure to 
TCS (Figure 1 A, B). At 8 hpf the mortality rate did not differ significantly among treatments. 
At 32 hpf the mortality rate ranged from 3.75 ± 3.75 in the 1 µg/L treatment to 12.50 ± 3.66 
in the first assay solvent control and 12.50 ± 2.50 in the 100 µg/L treatment. At 80 hpf, the 
mortality rate varied between 7.50 ± 3.66 in the 10 µg/L concentration to 100 in the 1000 
µg/L concentration of both assays. At the end of the assays, the mortality rate ranged from 
8.75 ± 3.50 in the 64 µg/L treatment (Figure 17 B) to 100 in the higher concentration (Figure 
17 A, B). For both assays, the results show a significant increase in the mortality rate 
(p<0.05) for the embryos exposed to the highest concentration (1000 µg/L) in comparison 
with all the other treatments except for the concentration immediately below (100 and 400 
µg/L) (Figure 17 A, B, respectively).  
 
 
 
 
 
 
 
 
 
 
 
  
3.1.1.2. Abnormal cell growth 
The percentage of embryos exhibiting abnormal cell growth at 8 hpf was similar between 
treatments and no significant differences (p>0.05) were reported for both assays (Figure 18 
A, B). 
 
 
 
Figure 17- Cumulative mortality rates (%) of D. rerio exposed to different concentrations of the 
disinfectant Triclosan for 144 h in the first assay (A) and second assay (B). Data are expressed as 
mean ± SE (n=8). Nonparametric ANOVA Kruskall-Wallis (p<0.05), followed by multiple comparisons 
between groups for both A and B. Bars with different letters are statistically different from each other. 
    46 
  
 
 
 
 
 
 
 
 
 
 
 
3.1.1.3. Embryo development delay  
In both assays no significant delay (p>0.05) in the embryonic development were 
observed (Figure 19).  
 
 
 
 
 
 
 
 
 
 
 
 
3.1.1.4. Hatching rate 
In the first assay, no significant differences (p>0.05) were reported in the hatching 
rate among treatments (Figure 20 A). In the second assay, the hatching rate ranged from 
61.25 ± 9.34 in the 400 µg/L concentration to 86.25 ± 3.75 in the solvent control and 86.25 
± 4.98 in the 64 µg/L treatment, respectively (Figure 20 B). This decrease on hatching was 
significantly different (p<0.05) from the solvent control and the 10 µg/L concentration (Figure 
Figure 19 - Embryo development delay at 32 hpf (%) of D. rerio exposed to different concentrations 
of the disinfectant Triclosan for 144 h. Data are expressed as mean ± SE (n=8). Nonparametric ANOVA 
Kruskall-Wallis.    
Figure 18 - Abnormal cell growth at 8 hpf (%) of D. rerio exposed to different concentrations of the 
disinfectant Triclosan for 144 h in the first assay (A) and second assay (B). Data are expressed as 
mean ± SE (n=8). Nonparametric ANOVA Kruskall-Wallis for A, One-way ANOVA for B. 
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20 B).  In both assays, embryos from the 10000 µg/L concentration were all dead at 80 hpf 
and so the hatching rate for this treatment was not reported. 
 
 
 
 
 
 
 
 
 
3.1.1.5. Head and eyes abnormalities 
In both assays, at 144 hpf, the percentage of head (Figure 21 A, B) and eyes 
abnormalities (Figure 22 A, B) in the embryos were similar among treatments and no 
significant differences (p>0.05) were detected. 
 
 
 
 
 
 
 
 
 
 
 
Figure 21 - Head abnormalities (%) of D. rerio exposed to different concentrations of the 
disinfectant Triclosan for 144 h in the first assay (A) and second assay (B). Data are expressed as 
mean ± SE (n=8). Nonparametric ANOVA Kruskall-Wallis (p<0.05), followed by multiple 
comparisons between groups for both A and B.  
Figure 20 - Hatching rate at 80 hpf (%) of D. rerio exposed to different concentrations of the 
disinfectant Triclosan for 144 h in the first assay (A) and second assay (B). Data are expressed as 
mean ± SE (n=8). Nonparametric ANOVA Kruskall-Wallis (p>0.05) for A and One-way ANOVA 
(p<0.05) for B. Bars with different letters are statistically different from each other. 
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3.1.1.6. Tail abnormalities  
At 144 hpf, the percentage of tail abnormalities was low and no significant 
differences (p>0.05) were detected among treatments (Figure 23 A, B). 
  
 
 
 
 
 
 
 
3.1.1.7. Yolk-sac abnormalities  
In the end of the first assay, the percentage of abnormalities on embryos’ yolk-sac 
was similar among treatments and no significant differences (p>0.05) were reported (Figure 
24 A). In the second assay, the percentage of yolk-sac abnormalities ranged from 0 in the 
water control and the 160 µg/L concentration to 17.71 ± 5.55 in the 400 µg/L treatment. This 
increase was significantly different (p<0.05) in comparison with all treatments (Figure 24 B).  
 
 
Figure 22 - Eyes abnormalities (%) of D. rerio exposed to different concentrations of the disinfectant 
Triclosan for 144 h in the first assay (A) and second assay (B).  Data are expressed as mean ± SE (n=8). 
Nonparametric ANOVA Kruskall-Wallis for both A and B. 
Figure 23 - Tail abnormalities (%) of D. rerio exposed to different concentrations of the disinfectant 
Triclosan for 144 h in the first assay (A) and second assay (B). Data are expressed as mean ± SE 
(n=8). Nonparametric ANOVA Kruskall-Wallis for both A and B. 
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3.1.1.8. Pericardial edema 
At 144 hpf, the percentage of pericardial edema on embryos from the first assay was 
not significantly different (p>0.05) among the different groups (Figure 25 A). In the end of 
the second assay, the percentage of pericardial edemas observed ranged from 0 in all 
treatments to 18.75 ± 5.84 in the 400 µg/L concentration. This increase was significantly 
different (p<0.05) in comparison with all treatments (Figure 25 B). 
 
 
 
 
 
 
 
 
 
 
 
Figure 25 - Pericardial edema abnormalities (%) of D. rerio exposed to different concentrations of 
the disinfectant Triclosan for 144 h in the first assay (A) and second assay (B). Data are expressed 
as mean ± SE (n=8). Nonparametric ANOVA Kruskall-Wallis, followed by multiple comparisons 
between groups for both (A) (p>0.05) and (B) (p<0.05). Bars with different letters are statistically 
different from each other. 
Figure 24 - Yolk-sac abnormalities (%) of D. rerio exposed to different concentrations of the 
disinfectant Triclosan for 144 h in the first assay (A) and second assay (B). Data are expressed as mean 
± SE (n=8). Nonparametric ANOVA Kruskall-Wallis for A (p>0.05) and B (p<0.05). 
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3.1.1.9. Hemorrhages  
No significant differences (p>0.05) were observed among groups for this endpoint 
(Figure 26 A, B). 
 
 
 
 
 
 
 
 
3.1.1.10. Muscular involuntary contractions 
In the first assay, the rate of muscular involuntary contractions was similar among 
treatments and no significant differences (p>0.05) were reported (Figure 27 A). In the 
second assay, at the end of the assay the percentage of muscular involuntary contractions 
ranged from 0 in the water control to 82.29 ± 12.24 in the 400 µg/L treatment. This increase 
was significantly different (p<0.05) in comparison to all groups (Figure 27 B). 
 
 
 
 
 
 
 
 
 
Figure 26 - Hemorrhages (%) of D. rerio exposed to different concentrations of the disinfectant Triclosan 
for 144 h in the first assay (A) and second assay (B). Data are expressed as mean ± SE (n=8). 
Nonparametric ANOVA Kruskall-Wallis for A. ANOVA Kruskall-Wallis for B. 
 
Figure 27 - Muscular involuntary contractions at 144 hpf (%) of D. rerio exposed to different 
concentrations of the disinfectant Triclosan for 144 h in the first assay (A) and second assay (B). Data 
are expressed as mean ± SE (n=8). Nonparametric ANOVA Kruskall-Wallis for A (p>0.05) and B 
(p<0.05), followed by multiple comparisons between groups for B. Bars with different letters are 
statistically different from each other. 
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3.1.1.11. Total abnormalities 
For the first assay, no significant differences were detected (p>0.05) for this endpoint 
at the end of the assay (Figure 28 A). In the second assay, the percentage of total 
abnormalities ranged from 0 in the 160 µg/L concentration to 100 in the 400 µg/L treatment. 
This increase was significantly higher (p>0.05) in comparison with all treatments (Figure 28 
B).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
A B 
Figure 29 - D. rerio at 144 hpf in the control group (A) and exposed 
to 400 µg/L of the disinfectant Triclosan (B). The black arrows point 
the malformations on embryos’ yolk-sac and pericardial edemas. 
Figure 28 - Total abnormal embryos (%) of D. rerio exposed to different concentrations of the 
disinfectant Triclosan for 144 h in the first assay (A) and second assay (B). Data are expressed as 
mean ± SE (n=8). Nonparametric ANOVA Kruskall-Wallis for both A (p>0.05) and B (p<0.05), followed 
by multiple comparisons between groups for B. Bars with different letters are statistically different from 
each other. 
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3.1.1.12. Heart rate 
No significant differences (p>0.05) were found in the embryos heart rate at the end of  
both assays (Figure 30 A, B).  
 
  
  
 
 
 
 
 
3.1.2. Sea urchin embryo bioassay  
3.1.2.1. Larval length and abnormalities 
 For the P. lividus exposure assay to triclosan, 8 different concentrations were tested. 
Given that no differences were observed between solvent and water controls, they were 
grouped. The larval length ranged from 262.9 ± 14.6 in the 400 µg/L concentration to 454.8 
± 6.1 in the controls, exhibiting a significant decrease (p<0.05) on the larval length for the 
400 µg/L and 100 µg/L concentration (Figure 31 A). In the end of the assay the larvae 
exposed to 1000 µg/L of triclosan were all in the 2 or 4-cell stage. The percentage of 
abnormal larvae ranged from 12.5 ± 1.26 in the 16 µg/L concentration to 100 in the higher 
concentrations (400, 1000 µg/L), and differed significantly in comparison with other 
treatments (Figure 31 B). 
 
 
 
 
 
 
Figure 30 - Heart rate (bpm) of D. rerio exposed to different concentrations of the disinfectant 
Triclosan for 144 h in the first assay (A) and second assay (B). Data are expressed as mean ± SE 
(n=8). One-way ANOVA for A. Nonparametric ANOVA Kruskall-Wallis for B.  
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A B 
C 
Figure 32 – P. lividus at 48 hpf in the control group (A), and exposed to 400 µg/L (B) and 1000 
µg/L of triclosan.  
Figure 31 - Larval length (µm) and abnormalities rate (%) of P. lividus (A and B, respectively) 
exposed to different concentrations of the disinfectant triclosan for 48h. Data are expressed as mean 
± SEM (n=480 for each control; n=120 for triclosan exposed groups; n=15 for 400 µg/L treatment). 
Non-parametric ANOVA Kruskall-Wallis (p<0.05), followed by multiple comparisons between groups 
for both A and B. Bars with different letters are statistically different from each other. 
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3.2. Methyl-triclosan (M-TCS) 
3.2.1. Zebrafish embryos bioassay 
3.2.1.1. Cumulative mortality  
For methyl-triclosan two assays were also conducted. Until 80 hpf, the mortality rate 
was similar between treatments in both assays. At 144 hpf the mortality ranged from 1.25 
± 1.25 in the second assay water control (Figure 33 B) to 97.5 ± 2.50 in the 10000 µg/L 
concentration (Figure 33 A). The increase in the mortality rate in the first assay in the 10000 
µg/L concentration was significantly different (p<0.05) in comparison with the other groups 
excepting for the 1000 µg/L concentration (Figure 33 A). As in the second assay, for the 
higher concentration (1000 µg/L concentration) was detected a significant increase (p<0.05) 
comparing to the treatments and controls (Figure 33 B). The mortality rate in the 1000 µg/L 
concentration was slightly different between assays. In the first assay was 26.25 ± 8.85 as 
in the second assay reached 41.3 ± 13.42. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33 - Cumulative mortality rates (%) of D. rerio exposed to different concentrations of   methyl 
–triclosan for 144 h in the first assay (A) and second assay (B).  Data are expressed as mean ± SE 
(n=8). Nonparametric ANOVA Kruskall-Wallis (p<0.05), followed by multiple comparisons between 
groups for A. One-way ANOVA for B (p<0.05). Bars with different letters are statistically different from 
each other. 
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3.2.1.2. Abnormal cell growth 
In both assays no significant differences (p>0.05) were detected in this endpoint 
among treatments (Figure 34 A, B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.1.3. Embryo development delay  
The percentage of embryos with development delay was similar among groups and 
no significant differences (p>0.05) were detected (Figure 35 A, B).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34 - Abnormal cell growth at 8 hpf (%) of D. rerio exposed to different concentrations of 
methyl-triclosan for 144 h in the first assay (A) and second assay (B). Data are expressed as mean ± 
SE (n=8). One-way ANOVA for A. Nonparametric ANOVA Kruskall-Wallis for B. 
Figure 35 - Embryo development delay at 32 hpf (%) of D. rerio exposed to different concentrations 
of methyl-triclosan for 144 h in the first assay (A) and second assay (B).. Data are expressed as 
mean ± SE (n=8). Nonparametric ANOVA Kruskall-Wallis for both A and B.    
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3.2.1.4. Hatching rate 
The hatching rate did not differ significantly (p>0.05) among treatments in both assays 
(Figure 36 A, B).  
 
 
 
 
 
 
 
  
3.2.1.5. Head and eyes abnormalities 
During both assays no significant differences  (p>0.05)  on the percentage of head 
or eyes abnormalities were detected (Figure 37 A, B).  
 
 
 
 
 
 
 
 
 
 
Figure 36 -Hatching rate at 80 hpf (%) of D. rerio exposed to different concentrations of methyl-triclosan 
for 144 h in the first assay (A) and second assay (B). Data are expressed as mean ± SE (n=8). 
Nonparametric ANOVA Kruskall-Wallis for A and One-way ANOVA for B.  
Figure 37 - Head and eyes abnormalities (%) of D. rerio exposed to different concentrations of the 
disinfectant Triclosan for 144 h in the second assay (A and B, respectively). Data are expressed as 
mean ± SE (n=8; for 1000 µ/L n= 6). Nonparametric ANOVA Kruskall-Wallis (p<0.05), for both A and 
B. 
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3.2.1.6. Tail abnormalities   
Tail abnormalities ranged from 0 to 100% in the 10000 and 1000 µg/L concentrations 
in both assays (Figure 38 A, B). The increases in the first assay were significantly different 
(p<0.05) in comparison with all groups (Figure 38 A), whereas in the second assay, the 
increases in the 1000 and 400 µg/L concentrations were only significantly different (p<0.05) 
in comparison with the solvent control and the 64 µg/L concentration (Figure 38 B).   
 
 
 
 
 
 
 
 
3.2.1.7. Yolk-sac abnormalities 
In the end of both assays, the percentage of yolk-sac abnormalities ranged from 0 to 
100 in the 1000 and 10000 µg/L concentration. This increase in both concentrations was 
significantly higher (p<0.05) in comparison with all the other treatments (Figure 39 A, B). 
 
 
  
 
 
 
 
 
Figure 38 - Tail abnormalities (%) of D. rerio exposed to different concentrations of methyl-triclosan 
for 144 h in the first assay (A) and second assay (B). Data are expressed as mean ± SE (n=8; for 
10000µ/L in A n=1; for 1000 µ/L in B n= 6). Nonparametric ANOVA Kruskall-Wallis for both A and B. 
Bars with different letters are statistically different from each other. 
Figure 39 - Yolk-sac abnormalities (%) of D. rerio exposed to different concentrations of methyl-
triclosan for 144 h in the first assay (A) and second assay (B). Data are expressed as mean ± SE (n=8; 
for 10000µ/L in A n=1; for 1000 µ/L in B n= 6). Nonparametric ANOVA Kruskall-Wallis for A and B. 
Barr with different letters are statistically different from each other. 
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3.2.1.8. Pericardial edema and Hemorrhages 
At 144 hpf, in both assays, the percentage of pericardial edema and hemorrhages 
on embryos was low and no significant differences (p<0.05) were detected among groups 
(Figure 40, 41 A, B).  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 40 – Pericardial edema (%) of D. rerio exposed to diferent concentrations of methyl-triclosan for 
144 hpf in the first assay (A) and second assay (B). Data are expressed as mean± SE (n=8; for 10000µ/L 
in A n=1; for 1000 µ/L in B n= 6). Nonparametric ANOVA Kruskall-Wallis for A and B.  
Figure 41 - Hemorrhages (%) of D. rerio exposed to different concentrations of methyl-triclosan for 
144 hpf in the first assay (A) and second assay (B). Data are expressed as mean± SE (n=8; for 
10000µ/L in A n=1; for 1000 µ/L in B n= 6). Nonparametric ANOVA Kruskall-Wallis for A and B.  
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3.2.1.9. Muscular involuntary contractions  
In both assays, at 144 hpf, the percentage of embryos with muscular involuntary 
contractions ranged from 0 to 100 in the 10000 and 1000 µg/L concentrations. This increase 
was significantly different (p<0.05) in comparison with the other groups (Figure 42 A, B). 
 
 
 
 
 
 
 
 
 
3.2.1.10. Total abnormalities 
At 144 hpf, the percentage of abnormal embryos ranged from 0 in the first assay 
solvent control to 100 in the two highest concentrations (10000 and 1000 µg/L). The 
increases in the 10000, 1000 and 400 µg/L concentrations were significantly different in 
comparison with all the other treatments apart from the 160 µg/L concentration (Figure 43 
A, B). 
 
 
 
 
 
 
 
 
Figure 42 - Muscular involuntary contractions (%) of D. rerio exposed to different concentrations of 
methyl-triclosan for 144 h (in the first assay (A) and second assay (B). Data are expressed as mean ± 
SE (n=8; for 10000µ/L in A n=1; for 1000 µ/L in B n= 6). Nonparametric ANOVA Kruskall-Wallis for A 
and B, followed by multiple comparisons between groups. Bars with different letters are statistically 
different from each other. 
Figure 43 - Total abnormal embryos (%) of D. rerio exposed to different concentrations of methyl-
triclosan for 144 h in the first assay (A) and second assay (B). Data are expressed as mean ± SE 
(n=8; for 10000µ/L in A n=1; for 1000 µ/L in B n= 6). Nonparametric ANOVA Kruskall-Wallis for both 
A and B. Followed by multiple comparisons between groups for B. Bars with different letters are 
statistically different from each other. 
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3.2.1.11. Heart rate 
At 144 hpf, the heart rate was similar between groups for both assays and so, no 
significant differences (p<0.05) were detected among groups (Figure 45 A, B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 45 - Heart rate (bpm) of D. rerio exposed to different concentrations of methyl-triclosan for 
144 h in the first assay (A) and second assay (B). Data are expressed as mean ± SE (n=8; for 
10000µ/L in A n=1; for 1000 µ/L in B n= 6). One-way ANOVA for both A and B.  
A B
B 
C
B 
Figure 44 - D. rerio at 144 hpf in the control group (A), exposed to 400 µg/L (B) and 1000 µg/L (C) 
of methyl-triclosan. The black arrows point the embryos malformations. 
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3.2.2. Sea urchin embryo bioassay  
3.2.2.1. Larval length and abnormalities 
In the methyl-triclosan exposure, the larval length ranged from 265.9 ± 8.96 in the 
1000 µg/L concentration to 448.4 ± 5.9 in the controls. All the treatments were significantly 
different (p<0.05) from the controls (Figure 46 A). The percentage of abnormal larvae 
ranged from 5 ± 1.67 in the 16 µg/L concentration to 31.67 ± 2.75 in the 1000 µg/L 
concentration. The percentage of abnormalities was significantly higher in the 1000 µg/L 
treatment (p<0.05) in comparison with all the other treatments (Figure 46 B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
Figure 47 – P. lividus at 48 hpf in the control group (A) and exposed to 1000 µg/L of methyl-
triclosan (B). 
Figure 46 - Larval length (µm) and abnormalities rate (%) of P. lividus (A and B, respectively) 
exposed to different concentrations of methyl-triclosan for 48h. Data are expressed as mean ± SEM 
(n=480 for each control; n=120 for triclosan exposed groups). Non-parametric ANOVA Kruskall-Wallis 
(p<0.05), followed by multiple comparisons between groups for A. One way ANOVA (p<0.05) for B. 
Bars with different letters are statistically different from each other. 
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3.3. Perfluorooctane sulfonate (PFOS) 
3.3.1. Zebrafish embryos bioassay 
3.3.1.1. Cumulative mortality  
In the end of PFOS exposure assay, the mortality rate ranged from 13.75 ± 4.6 in the 
100 µg/L concentration to 100 in the highest concentration. The increase in the mortality 
rate in this last treatment was significantly different (p<0.05) from all groups, apart from the 
10 µg/L concentration (Figure 48). 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.1.2. Abnormal cell growth and embryo development delay 
No significant differences (p>0.05) were reported between treatments for both 
endpoints (Figure 49 A, B).  
 
 
 
 
 
 
 
 
Figure 48 - Cumulative mortality rates (%) of D. rerio exposed to different concentrations of PFOS for 144 
h. Data are expressed as mean ± SE (n=8). Nonparametric ANOVA Kruskall-Wallis, followed by multiple 
comparisons between groups. Bars with different letters are statistically different from each other. 
Figure 49 - Abnormal cell growth at 8 hpf and embryo development delay at 32 hpf (%) of D. rerio 
exposed to different concentrations of PFOS for 144 h (A and B, respectively). Data are expressed as 
mean ± SE (n=8). One-way ANOVA for A. Nonparametric ANOVA Kruskall-Wallis for B. 
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3.3.1.3. Hatching rate 
At 80 hpf, the hatching rate exhibited no significant differences (p>0.05) among 
treatments (Figure 50). 
 
 
 
 
 
 
 
 
3.3.1.4. Head abnormalities 
At the end of the assay, no head abnormalities were detected on embryos (Figure 51). 
 
3.3.1.5. Eyes abnormalities 
During the assay no eyes abnormalities were detected.  
 
Figure 50 - Hatching rate at 80 hpf (%) of D. rerio exposed to different concentrations of PFOS for 144 
h  Data are expressed as mean ± SE (n=8). One-way ANOVA. 
 
Figure 51 - Head abnormalities (%) of D. rerio exposed to different concentrations of PFOS for 144 h. 
Data are expressed as mean ± SE (n=8).  
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3.3.1.6. Tail and yolk-sac abnormalities 
At 144 hpf the percentage of tail and yolk-sac abnormalities were similar among 
groups and no significant differences (p>0.05) were reported (Figure 52 A, B). 
 
 
 
 
 
 
 
 
 
3.3.1.7. Pericardial edema and hemorrhages   
At 144 hpf, the percentage of pericardial edema and hemorrhages on embryos was 
low and no significant differences (p>0.05) were reported on both endpoints (Figure 53 A, 
B). 
 
 
 
 
 
 
 
 
3.3.1.8. Muscular involuntary contractions  
During the assay, no muscular involuntary contractions were detected on embryos. 
 
Figure 52 -Tail and yolk-sac abnormalities (%) of D. rerio exposed to different concentrations of PFOS 
for 144 h (A and B, respectively). Data are expressed as mean ± SE (n=8). Nonparametric ANOVA 
Kruskall-Wallis for A. One-way ANOVA for B. 
Figure 53 - Pericardial edema and hemorrhages (%) of D. rerio exposed to different concentrations of 
PFOS for 144 h (A and B, respectively). Data are expressed as mean ± SE (n=8). One-way ANOVA for A. 
Nonparametric ANOVA Kruskall-Wallis for B. 
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3.3.1.9. Total abnormalities and heart rate 
At 144 hpf the percentage of abnormal embryos and heart rate exhibited no significant 
differences (p>0.05) among treatments (Figure 54 A, B). In the 10000 µg/L concentration 
the embryos were all dead.  
 
 
 
 
 
  
 
 
3.3.2. Sea urchin embryo bioassay  
3.3.2.1. Larval length and abnormalities 
At the end of the assay, the larval length ranged from 358.92 ± 15.76 in the highest 
treatment to 385.61 ± 13.07 in the 6.4 µg/L concentration. The decrease on the 1000 and 
2.56 µg/L treatments was significantly different (p<0.05) in comparison with all groups 
except for the 100 µg/L concentration (Figure 55 A). The percentage of abnormal larvae 
ranged from 17.1 ± 1.72 in controls to 31.7 ± 5 in the 1000 µg/L concentration. No significant 
differences (p>0.05) were reported (Figure 55 B). 
 
 
 
 
 
 
 
 
Figure 54 - Total abnormal embryos (%) and heart rate (bpm) of D. rerio exposed to different 
concentrations of PFOS for 144 h. Data are expressed as mean ± SE (n=8). Nonparametric ANOVA 
Kruskall-Wallis for A. One-way ANOVA for B. 
Figure 55 - Larval length (µm) and abnormalities rate (%) of P. lividus (A and B, respectively) 
exposed to different concentrations of PFOS for 48h. Data are expressed as mean ± SEM (n=480 for 
controls; n=120 for PFOS exposed groups; n=90 for 1.204 µg/L and n=105 for 400 µg/L treatments). 
Non-parametric ANOVA Kruskall-Wallis (p<0.05), followed by multiple comparisons between groups 
for both A. One-way ANOVA for B (p>0.05). Bars with different letters are statistically different from 
each other. 
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3.4. Perfluorooctanoic acid (PFOA) 
3.4.1. Zebrafish embryos bioassay 
For PFOA exposure assay, the same four concentrations were tested. No significant 
differences (p>0.05) were detected for any of the endpoints considered. Table 3 
summarizes PFOA exposure effects on zebrafish at the end of the assay. 
 
3.4.2. Sea urchin embryo bioassay  
3.4.2.1.  Larval length and abnormalities 
At the end of the assay, the larval length ranged from 360.33 ± 20.32 in 1000 µg/L 
concentration to 409.47 ± 14.2 in 2.56 µg/L concentration. The decrease in the higher 
concentration and the 40 and 100 µg/L concentrations was significantly different (p>0.05) 
in comparison with all the other groups (Figure 56 A). Regarding abnormalities, the 
percentage of abnormal larvae ranged from 8.3 ± 4.05 in 2.56 µg/L concentration to 24.2 ± 
6.03 in 6.4 µg/L concentration. No significant differences (p>0.05) were reported (Figure 56 
B). 
 
Figure 56 - Larval length (µm) and abnormalities rate (%) of P. lividus (A and B, respectively) 
exposed to different concentrations of PFOA for 48h. Data are expressed as mean ± SEM (n=480 for 
controls; n=120 for PFOA exposed groups; n=105 for 100, 400 and 1000 µg/L treatments; n= 90 for 
2.56 µg/L treatment). Non-parametric ANOVA Kruskall-Wallis, followed by multiple comparisons 
between groups for both A. One-way ANOVA for B. Bars with different letters are statistically different 
from each other. 
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ENDPOINT (%) 
TREATMENT 
Water control Solvent control 10 µg/L 100  µg/L 1000  µg/L 10000  µg/L 
Mortality 12.50 ± 4.12 12.50 ± 2.50 10 ± 2.67 8.75 ± 2.27 15 ± 3.27 11.3 ± 2.95 
Abnormal cell 
growth(a) 
3.75 ± 2.63 1.25 ± 1.25 2.50 ± 1.64 1.25 ± 1.25 3.75 ± 1.83 3.75 ± 2.63 
Development 
delay(a) 
6.25 ± 3.05 4.17 ± 2.73 0  2.08 ± 2.08 2.08 ± 2.08 0  
Hatching(b) 86.25 ± 5.65 83.75 ± 3.75 87.50 ± 3.66 87.50 ± 2.50 80 ± 4.23 81.25 ± 2.27 
Head abnormalities 0 0 2.08 ± 2.08 0 0 0 
Eyes abnormalities 0 0 0 0 0 0 
Tail abnormalities 2.08 ± 2.08 6.25 ± 3.05 0 0 0 4.17 ± 2.73 
Yolk-sac 
abnormalities 
2.08 ± 2.08 2.08 ± 2.08 2.08 ± 2.08 2.08 ± 2.08 0 0 
Pericardial edema 4.17 ± 2.73 2.08 ± 2.08 2.08 ± 2.08 2.08 ± 2.08 0 0 
Hemorrhages 0 0 0 0 0 0 
Muscular involuntary 
contractions 
0 0 0 0 0 0 
Total abnormalities  6.25 ± 4.38 4.17 ± 2.73 4.17 ± 2.73 2.08 ± 2.08 0 4.17 ± 2.73 
Heart rate 127.5 ± 5.1 119.5 ± 6.39 124 ± 3.02 120.5 ± 3.06 124 ± 5.18 121  ± 2.24 
Table 3 - Effects of PFOA exposure in zebrafish embryos at 144 hpf. Data are expressed as mean ± se (n=8). 
(a)8 hpf   (b)80 hpf  
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3.5. Perfluorobutane sulfonate (PFBS) 
3.5.1. Zebrafish embryos bioassay 
In the PFBS exposure, no significant differences (p>0.05) were detected for any of the 
endpoints considered. Similarly to PFOA, in Table 4 are summarized the effects of PFBS 
exposure in the end of the assay.  
 
3.5.2. Sea urchin embryo bioassay  
3.5.2.1.  Larval length and abnormalities 
 At 48 hpf, the larval length ranged from 360.37 ± 17.22 in the 1000 µg/L 
concentration to 398.37 ± 13.13 µg/L in the 6.4 µg/L concentration. The increase in the 6.4 
µg/L concentration was significantly different (p<0.05) from the controls, as in the decrease 
in the higher concentration was significantly different (p<0.05) from the controls (Figure 57 
A). No significant differences (p>0.05) were reported for the endpoint larvae abnormalities 
(Figure 57 B). 
 
 
 
 
 
 
 
 
 
Figure 57 - Larval length (µm) and abnormalities rate (%) of P. lividus (A and B, respectively) 
exposed to different concentrations of PFBS for 48h. Data are expressed as mean ± SEM (n=450 for 
each control; n=120 for triclosan exposed groups; n=105 for 2.56 µg/L treatment). Non-parametric 
ANOVA Kruskall-Wallis (p<0.05), followed by multiple comparisons between groups for both A. One-
way ANOVA for B. Bars with different letters are statistically different from each other. 
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ENDPOINT (%) 
TREATMENT 
Water control Solvent control 10 µg/L 100  µg/L 1000  µg/L 10000  µg/L 
Mortality 5 ± 1.89 5 ± 2.67 2.5 ± 1.64 4.03 ± 2.88 3.75 ± 1.83 7.5 ± 4.12 
Abnormal cell 
growth(a) 
2.5 ± 1.64 0 1.25 ± 1.25 2.5 ± 1.64 2.5 ± 1.64 1.25 ± 1.25 
Development 
delay(a) 
2.08 ± 2.08 0 0 2.08 ± 2.08 2.08 ± 2.08 0 
Hatching(b) 87.5 ± 3.66 93.75 ± 2.63 96.25 ± 1.83 84.86 ± 7.06 92.5 ± 2.5 91.25 ± 3.5 
Head abnormalities 0 0 0 0 0 0 
Eyes abnormalities 0 0 0 0 0 0 
Tail abnormalities 2.08 ± 2.08 6.25 ± 4.38 6.25 ± 3.05 4.17 ± 2.73 4.17 ± 2.73 2.08 ± 2.08 
Yolk-sac 
abnormalities 
0 0 0 2.08 ± 2.08 2.08 ± 2.08 6.25 ± 3.05 
Pericardial edema 0 0 0 0 0 2.08 ± 2.08 
Hemorrhages 0 0 0 0 0 0 
Muscular involuntary 
contractions 
0 0 0 0 2.08 ± 2.08 0 
Total abnormalities  2.08 ± 2.08 6.25 ± 4.38 6.25 ± 3.05 6.25 ± 3.05 4.17 ± 2.73 8.33 ± 3.15 
Heart rate 126 ± 3.46 130 ± 3.63 127.5 ± 2.2 130 ± 3.02 127.5 ± 3.5 126 ± 2.93 
Table 4 - Effects of PFBS exposure in zebrafish embryos at 144 hpf. Data are expressed as mean ± SE (n=8). 
 
(a)8 hpf   (b)80 hpf  
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3.6. Perfluorobutanoic acid (PFBA) 
3.6.1. Zebrafish embryos bioassay 
At the end of the assay, no significant differences (p>0.05) were detected in any of the 
endpoints. Table 5 summarizes PFBA exposure to zebrafish in the end of the assay.  
 
3.6.2. Sea urchin embryo bioassay  
3.6.2.1. Larval length and abnormalities 
 In PFBA exposure assay, the larval length ranged from 378.36 ± 16.3 in the 1000 
µg/L treatment to 402.73 ± 12.48 in the 100 µg/L concentration. The decrease in the larval 
length from the 1000, 400 and 2.56 µg/L treatments were significantly different (p<0.05) 
from the 100 µg/L concentration (Figure 58 A).  For the larvae abnormalities percentage, it 
ranged from 23.54 ± 1.87 in controls to 39.17 ± 4.62 in the 100 µg/L concentration. No 
significant differences (p>0.05) were detected among groups (Figure 58 B). 
 
 
  
 
 
 
Figure 58 - Larval length (µm) and abnormalities rate (%) of P. lividus (A and B, respectively) 
exposed to different concentrations of PFBA for 48h. Data are expressed as mean ± SEM (n=480 for 
controls; n=120 for PFBA exposed groups; n=105 for 2.56 µg/L treatment). Non-parametric ANOVA 
Kruskall-Wallis (p<0.05), followed by multiple comparisons between groups for both A and B (p>0.05). 
Bars with different letters are statistically different from each other. 
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ENDPOINT (%) 
TREATMENT 
Water control Solvent control 10 µg/L 100  µg/L 1000  µg/L 10000  µg/L 
Mortality 11.07 ± 4.5 11.25 ± 2.95 8.75 ± 2.27 15 ± 4.63 6.25 ± 2.63 18.8 ± 5.81 
Abnormal cell 
growth(a) 
9.82 ± 4.71 10 ± 2.67 7.5 ± 1.64 10 ± 2.67 5 ± 1.89 15 ± 4.23 
Development 
delay(a) 
6.25 ± 4.38 0 0 0 0 0 
Hatching(b) 81.7 ± 4.9 87.5 ± 3.13 88.75 ± 3.5 82.5 ± 5.26 83.75 ± 4.98 77.5 ± 5.9 
Head abnormalities 0 0 0 0 0 0 
Eyes abnormalities 0 0 0 0 0 0 
Tail abnormalities 2.08 ± 2.08 4.17 ± 2.73 4.17 ± 2.73 4.17 ± 2.73 2.08 ± 2.08 2.08 ± 2.08 
Yolk-sac 
abnormalities 
4.17 ± 2.73 2.08 ± 2.08 6.25 ± 3.05 2.08 ± 2.08 2.08 ± 2.08 0 
Pericardial edema 0 0 2.08 ± 2.08 0 2.08 ± 2.08 0 
Hemorrhages 0 0 0 0 0 0 
Muscular involuntary 
contractions 
0 0 0 0 2.08 ± 2.08 0 
Total abnormalities  4.17 ± 2.73 4.17 ± 2.73 8.33 ± 4.45 6.25 ± 3.05 4.17 ± 2.73 2.08 ± 2.08 
Heart rate 122 ± 5.76 121.5 ± 7.63 122.5 ± 5.07 128.5 ± 3.33 112 ± 3.85 112 ± 4.47 
Table 5 - Effects of PFBA exposure in zebrafish embryos at 144 hpf. Data are expressed as mean ± SE (n=8). 
(a)8 hpf   (b)80 hpf  
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3.7. Perfluorodecanoic acid (PFDA) 
3.7.1. Zebrafish embryos bioassay 
3.7.1.1. Cumulative mortality 
 For PFDA exposure assay, the mortality rate was low and at 144 hpf, ranged from 1.25 
± 1.25 to 5 ± 1.89 in water control and 5 ± 2.67 in solvent control and 10 µg/L concentration. 
No significant differences (p>0.05) were reported between groups (Figure 59). 
 
 
 
 
 
 
 
 
 
 
3.7.1.2. Abnormal cell growth and embryo development delay  
The percentage of embryos exhibiting abnormal cell growth at 8 hpf and the embryo 
development delay at 32 hpf were similar among groups and no significant differences 
(p>0.05) were observed among treatments (Figure 60 A, B). 
 
 
 
 
 
 
 
 
 
 
Figure 59 - Cumulative mortality rates (%) of D. rerio exposed to different concentrations of PFDA for 
144 h. Data are expressed as mean ± SE (n=8). One-way ANOVA. 
Figure 60 - Abnormal cell growth at 8 hpf and embryo development delay at 32 hpf (%) of D. rerio 
exposed to different concentrations of PFDA for 144 h (A and B, respectively). Data are expressed as 
mean ± SE (n=8). Nonparametric ANOVA Kruskall-Wallis for both A and B. 
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3.7.1.3. Hatching rate 
At 80 hpf, the percentage of hatched embryos ranged from 86.25 ± 3.24 in the higher 
concentration to 97.50 ± 1.64 in the 10 µg/L concentration. No significant differences 
(p>0.05) among groups were reported (Figure 61). 
 
3.7.1.4. Head and eyes abnormalities 
During the assay, no head or eyes abnormalities were detected on embryos during 
the assay. 
 
3.7.1.5. Tail and yolk-sac abnormalities 
At 144 hpf, the percentage of tail abnormalities ranged from 0 in the water control and 
the first treatment to 12.50 ± 4.17 in the highest concentration. All the tail abnormalities in 
the higher concentration at 144 hpf represent spinal curvatures (Figure 62 A). This increase 
was significantly different from the water control and the 10 µg/L concentration. The yolk-
sac abnormalities rate was low and no significant differences (p>0.05) were reported (Figure 
62 B). 
 
 
 
 
 
Figure 61 - Hatching rate at 80 hpf (%) of D. rerio exposed to different concentrations of PFDA for 144 h 
(A and B, respectively). Data are expressed as mean ± SE (n=8). One-way ANOVA. 
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3.7.1.6. Pericardial edema and hemorrhages   
At the end of the assay the percentage of pericardial edemas was low and no 
significant differences (p>0.05) were reported between treatments (Figure 64 A). No 
hemorrhages were detected at 144 hpf (Figure 64 B). 
 
 
 
 
 
Figure 62 - Tail and yolk-sac abnormalities (%) of D. rerio exposed to different concentrations of PFDA 
for 144 h (A and B, respectively). Data are expressed as mean ± SE (n=8). Nonparametric ANOVA 
Kruskall-Wallis followed by multiple comparisons between groups for both A (p<0.05) and B (p>0.05). 
Bars with different letters are statistically different from each other. 
Figure 63 – D. rerio embryos at 144 hpf exposed to 10000 µg/L of PFDA. The black arrow 
points the abnormal embryo, exhibiting spinal curvature. 
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3.7.1.7. Muscular involuntary contractions 
During the assay, no muscular involuntary contractions were observed. 
 
3.7.1.8. Total abnormalities and heart rate 
At 144 hpf the percentage of abnormal embryos ranged from 0 in the water control 
and the first treatment to 12.50 ± 4.17 in the 10000 µg/L concentration. This increase was 
significantly different (p<0.05) from the water control and the first treatment (Figure 65 A). 
No significant differences (p>0.05) were reported in the embryos heart rate (Figure 65 B).  
 
 
 
 
 
 
 
 
 
 
Figure 65 – Total abnormal embryos (%) and heart rate (bpm) of D. rerio exposed to different 
concentrations of PFDA for 144 h (A and B, respectively). Data are expressed as mean ± SE (n=8). 
Nonparametric ANOVA Kruskall-Wallis for A (p<0.05). One-way ANOVA for B (p>0.05). Bars with 
different letters are statistically different from each other. 
Figure 64 - Pericardial edema and hemorrhages (%) of D. rerio exposed to different concentrations of 
PFDA for 144 h (A and B, respectively). Data are expressed as mean ± SE (n=8). Nonparametric ANOVA 
Kruskall-Wallis (p>0.05) for A. 
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3.7.2. Sea urchin embryo bioassay  
3.7.2.1. Larval length and abnormalities 
 At the end of the assay, the larval length ranged from 402.92 ± 17.66 in the 1000 
µg/L concentration to 452.33 ± 14.27 in the 400 µg/L concentration. The decrease larvae 
length in the highest concentration was significantly different (p<0.05) in comparison with 
all the other groups (Figure 66 A).  The 16 µg/L concentration was significantly different 
(p<0.05) from the 40 and 400 µg/l concentrations (Figure 66 A). The abnormalities rate 
ranged from 8.89 ± 4.01 in the 2.56 µg/L treatment to 18.89 ± 3.18 in the highest 
concentration. No significant differences (p>0.05) were reported among groups (Figure 66 
B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 66 - Larval length (µm) and abnormalities rate (%) of P. lividus (A and B, respectively) 
exposed to different concentrations of PFDA for 48h. Data are expressed as mean ± SEM (n=360 for 
controls; n=90 for PFDA exposed group). Non-parametric ANOVA Kruskall-Wallis (p<0.05), followed 
by multiple comparisons between groups for A. One way ANOVA for B. Bars with different letters are 
statistically different from each other. 
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3.8. Perfluoroundecanoic acid (PFUnA) 
3.8.1. Zebrafish embryos bioassay 
3.8.1.1. Cumulative mortality  
In this assay, no mortality was observed in all groups at 8 hpf. At the end of the assay, 
144 hpf, the mortality ranged from 8.75 ± 2.27 in the water control and 8.75 ± 3.50 in the 
1000 µg/L concentration to 81.3 ± 3.5 in 10000 µg/L concentration. At this last observation 
time-point, the increased mortality in the highest treatment was significantly different 
(p<0.05) in comparison with all the other groups (Figure 67).  
 
 
 
 
 
 
 
 
 
3.8.1.2. Abnormal cell growth  and embryo development delay 
No significant differences (p>0.05) were detected among groups for both endpoints 
(Figure 68 A, B). 
 
 
 
 
 
 
 
 
 
Figure 67 - Cumulative mortality rates (%) of D. rerio exposed to different concentrations of PFUnA for 
144 h. Data are expressed as mean ± SE (n=8). One-way ANOVA. Bars with different letters are 
statistically different from each other 
Figure 68 - Abnormal cell growth at 8 hpf and embryo development delay at 32 hpf (%) of D. rerio 
exposed to different concentrations of PFUnA for 144 h (A and B, respectively). Data are expressed as 
mean ± SE (n=8). One-way ANOVA for A. Nonparametric ANOVA Kruskall-Wallis for B. 
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3.8.1.3. Early hatching and hatching rate 
At 24 hpf, the percentage of embryos hatched ranged from 0 in both controls and the 
lowest exposure group to 58.33 ± 11.79 in the highest concentration. This increase was 
significantly different (p<0.05) in comparison with all the other treatments (Figure 69 A). The 
hatching rate at 80 hpf ranged from 35 ± 7.07 in the 10000 µg/L concentration to 95 ± 2.67 
in the 10 µg/L concentration. The hatching rate in the higher treatment was significantly 
different (p<0.05) in comparison to the 10 and 1000 µg/L concentrations (Figure 69 B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 70 – D. rerio embryos at 32 hpf exposed to 10000 µg/L of PFUnA. The black 
arrow points the early hatched embryo.  
Figure 69 – Early hatching at 24 hpf and Hatching rate at 80 hpf (%) of D. rerio exposed to different 
concentrations of PFUnA for 144 h (A and B, respectively). Data are expressed as mean ± SE (n=8). 
Nonparametric ANOVA Kruskall-Wallis for both A and B (p<0.05). Bars with different letters are statistically 
different from each other. 
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3.8.1.4. Head and eyes abnormalities 
The percentage of head abnormalities at 144 hpf exhibited no significant differences 
(p>0.05) among treatments (Figure 71). During this assay, no eyes abnormalities were 
detected on embryos.  
 
 
 
 
 
 
 
 
 
3.8.1.5. Tail and yolk-sac abnormalities 
The percentage of tail abnormalities at 144 hpf ranged from 4.17 ± 2.73 in the water 
control and 100 µg/L concentration to 27.78 ± 3.04 in the 10000 µg/L concentration.  This 
increase was significantly different (p<0.05) in comparison with all groups (Figure 72 A). At 
144 hpf, the percentage of embryos with yolk-sac abnormalities was low and no significant 
differences (p>0.05) were detected among groups (Figure 72 B). 
 
 
 
 
 
 
 
 
 
 
 
Figure 71 - Head abnormalities (%) of D. rerio exposed to different concentrations of PFUnA for 144 h . 
Data are expressed as mean ± SE (n=8). Nonparametric ANOVA Kruskall-Wallis. 
Figure 72 - Tail and yolk-sac abnormalities (%) of D. rerio exposed to different concentrations of 
PFUnA for 144 h (A and B, respectively). Data are expressed as mean ± SE (n=8). One-way ANOVA for 
A (p<0.05). Nonparametric ANOVA Kruskall-Wallis for B (p>0.05). Bars with different letters are 
statistically different from each other. 
 
80 
 
3.8.1.6. Pericardial edema and hemorrhages 
At 144 hpf the percentage of pericardial edema exhibited no significant differences 
(p>0.05) among treatments (Figure 73 A). No hemorrhages in embryos were detected at 
the end of the assay (Figure 73 B). 
 
 
 
 
 
 
 
 
 
3.8.1.7. Muscular involuntary contractions 
           During the assay, no muscular involuntary contractions were detected.   
3.8.1.8. Total abnormalities and heart rate 
At the end of the assay, the percentage of total abnormalities ranged from 4.17 ± 2.73 
in the water control and the 100 µg/L concentration to 40.48 ± 11.21 in the 10000 µg/L 
concentration. This increase was significantly different (p<0.05) among groups (Figure 74 
A). The heart rate ranged from 104.50 ± 6.57 in the 1000 µg/L concentration to 125.14 ± 
8.63 in highest concentration. No significant differences (p>0.05) were detected among 
groups (Figure 74 B). 
 
 
 
 
 
 
 
 
Figure 73 - Pericardial edema and hemorrhages (%) of D. rerio exposed to different concentrations of 
PFUnA for 144 h (A and B, respectively). Data are expressed as mean ± SE (n=8). Nonparametric ANOVA 
Kruskall-Wallis for A. 
Figure 74 - Total abnormal embryos (%) and heart rate (bpm) of D. rerio exposed to different 
concentrations of PFUnA for 144 h (A and B, respectively. Data are expressed as mean ± SE (n=8). One-
way ANOVA for A (p<0.05). Nonparametric ANOVA Kruskall-Wallis for B (p>0.05). Bars with different 
letters are statistically different from each other. 
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3.8.2. Sea urchin embryo bioassay  
3.8.2.1.  Larval length and abnormalities 
In the sea urchin exposure to PFUnA, the larval length ranged from 398.86 ± 14.23 
in the 1000 µg/L to 452.95 ± 11.8 in the 2.56 µg/L concentration. The increase in the 2.56 
µg/L concentration was significantly different (p<0.05) from all groups, except for the 100 
µg/L concentration, as in the decrease in the higher concentration was significantly different 
(p<0.05) in comparison with all the other groups (Figure 75 A). The percentage of 
abnormalities ranged from 12.5 ± 4.61 in the 1.024 µg/L concentration to 22.5 ± 2.8 in the 
1000 µg/L treatment. No significant differences (p>0.05) were reported among treatments 
(Figure 75 B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 75 - Larval length (µm) and abnormalities rate (%) of P. lividus (A and B, respectively) 
exposed to different concentrations of PFUnA for 48h. Data are expressed as mean ± SEM (n=480 
for controls; n=120 for PFUnA exposed group). One way ANOVA for both A (p<0.05) and B (p>0.05). 
Bars with different letters are statistically different from each other. 
 
Figure 76 – P.lividus at 48 hpf in the control group (A) and exposed to 1000 
µg/L of PFUnA (B). 
A B 
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Table 6 – Overview of the overall results, highlighting the significant effects (p<0.05) on both model embryo 
bioassays, for each compound. The [√] marks the significant endpoints that differed significantly from the 
control treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*at 80 hpf. 
 
 
         Table 7 - Overview of the NOECs and LOECs reported in this study (µg/L). 
 D. rerio P. lividus 
 NOEC LOEC NOEC LOEC 
TCS 160 400 40 100 
M-TCS 160 400 <1.024 1.024 
PFOS 1000 10000 1.024 2.56 
PFOA 10000 >10000 16 40 
PFBS 10000 >10000 2.56 6.4 
PFBA 10000 >10000 1000 >1000 
PFDA 10000 >10000 400 1000 
PFUnA 1000 10000 1.024 2.56 
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Mortality √ √ √     √ 
Abnormal Cell Growth         
Development Delay         
Hatching √        
Early hatching        √ 
Head abnormalities         
Eyes abnormalities         
Tail abnormalities  √      √ 
Yolk-sac abnormalities √ √       
Pericardial edema √        
Hemorrhages  √
*       
Muscular involuntary contractions √ √       
Heart rate         
Total abnormalities √ √       
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Larval length 
√ √ √ √ √  √ √ 
Abnormalities 
√ √       
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4. Discussion 
Toxicity assessment of chemicals using organisms’ embryonic development is a 
very sensitive and cost-effective alternative. The increasing use of several chemicals, along 
with the inefficiency of WWTP stations to complete remove several of these compounds 
and their metabolites, make this subject of great concern. Many of these compounds are 
released to the environment and the information about their mechanisms of action, 
bioaccumulative properties or even possible interactions with other chemicals are still not 
well understood. This work aimed at improving the toxicological data of two groups of 
emerging contaminants, i.e., the M-TCS, a metabolite of the disinfectant TCS, and the 
perfluorinated chemicals PFBS, PFBA, PFDA and PFUnA, in comparison with the well-
studied disinfectant TCS and perfluorinated chemicals PFOS and PFOA, respectively.  We 
performed embryo toxicity bioassays using two organisms from different taxonomic groups: 
the zebrafish (Danio rerio) and sea urchin (Paracentrotus lividus). The use of different 
species on chemicals’ toxicity assessment allows us to accomplish a more accurate 
evaluation on their toxicity, since chemicals can affect different biological routes to exert 
toxicity. Hence, it allow us to better predict chemicals’ impact on the aquatic ecosystems. 
Furthermore, some data extrapolation is possible since in zebrafish, the initial embryonic 
development stages are relatively well conserved among vertebrates and also, sea urchin 
being a deuterostomic, allows a better understanding of the mechanisms of action on 
conserved pathways. 
In general, our results revealed that sea urchin larvae were more sensitive to 
chemicals exposure than zebrafish. The greater sensibility of the sea urchin was also 
reported by Ribeiro et al., 2015 when exposed to different pharmaceuticals. This fact could 
be explained by the existence of a chorion in the zebrafish embryos that can work as a 
barrier to some chemicals, unlike the sea urchin larvae which is directly exposed to water 
pollutants. 
 Regarding zebrafish assays, our results show that TCS and M-TCS were both toxic 
to zebrafish, wherein TCS was apparently more toxic to zebrafish than its metabolite. TCS 
induced 100 % mortality on embryos at 80 hpf at a concentration of 1000 µg/L (Figure 17 
A, B) while M-TCS  induced 98 % mortality of embryos but at 144 hpf and at a concentration 
of 10000 µg/L (Figure 33 A). Comparing both compounds, for a concentration of 1000 µg/L, 
TCS induced 100% mortality at 80 hpf (Figure 17 A, B) while M-TCS induced mortality to 
40% of the embryos only at 144 hpf (Figure 33 B). Our results show that for the same 
concentration triclosan was more toxic during the first stages of development. In TCS 
bioassay, 400 µg/L were lethal to 56% of the embryos (Figure 17 B), which is in agreement 
with previous studies (Oliveira et al., 2009) whereas, in M-TCS bioassay no significant 
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mortality occurred for the same concentration. Regarding sub-lethal effects, Schmidt et al. 
(2013) observed a significant decrease in the heart rate at 100 µg/L of TCS, as in our assay 
no significant differences were observed in the embryos heart rate for both TCS and M-TCS 
(Figure 30 and 44 A, B). 
At 32 hpf we observed that TCS induced an increase in pericardial edema on 
embryos in the 1000 µg/L treatment (Figure 25 B). This abnormality could be an indication 
of TCS toxicity, since at 80 hpf was lethal to the embryos. On the other hand, M-TCS 
seemed to affect primarily the cardiovascular system, causing hemorrhages on embryos’ 
pericardial area, but only at 80 hpf (Figure 40 A, B), which resulted on death or severe 
abnormalities at 144 hpf. Although in different ways TCS and M-TCS seemed to affect 
primarily the pericardial area. At the end of the assay, M-TCS caused spinal curvature on 
embryos (Figure 37 A, B) along with yolk-sac abnormalities (Figure 38 A, B) and muscular 
involuntary contractions (Figure 71 A, B). Similarly, at lower concentrations (400 µg/L), TCS 
induced yolk-sac abnormalities (Figure 24 B) and muscular involuntary contractions (Figure 
27 B) but no tail abnormalities were observed (Figure 23 B). One possible justification for 
these results could be related with the fact that both compounds can target different 
signaling pathways. However, the mechanism of action of TCS and its methylation 
byproduct on aquatic species is not well understood. A non-specific narcosis on tissue is 
another plausible hypothesis for triclosan toxicity (Lyndall et al., 2010).   
For sea urchin bioassay, both endpoints (larval length and percentage of 
abnormities) were significantly affected by TCS and M-TCS. Although TCS reduced larval 
length at all concentrations, only at 100 µg/L was significantly different from controls (Figure 
31 A). Regarding the percentage of abnormalities, in the two highest treatments (1000 and 
400 µg/L), TCS affected larvae development whereas in the highest concentration all larvae 
were in 2 or 4-cell stage (Figure 32 B). At 400 µg/L, TCS also delayed larvae development, 
yet, some larvae reached an abnormal pluteus stage (Figure 32 B). M-TCS affected 
significantly the larval length at all concentrations (Figure 46 A), but only the highest 
concentration (1000 µg/L) increased significantly the percentage of abnormalities (Figure 
46 B). Both compounds seemed to be very toxic to the sea urchin larvae. Contrarily to 
zebrafish assay, M-TCS seemed to affect the organism at lower concentrations than the 
parental compound. Yet, it was not as toxic as TCS for the two higher concentrations. Thus, 
for higher concentrations, TCS was more toxic than its metabolite, affecting the larvae in 
the first hours after fertilization, but for lower concentrations, sea urchin larvae were more 
sensitive to M-TCS. The concentrations tested were of environmental relevance for 
triclosan, whereas, M-TCS has been detected in the order of ng/L range (Table 8).  
Recently, a study conducted on TCS toxicity with sea urchin reported that TCS 
affected the larvae development of Strongylocentrotus nudus at 113 µg/L (Hwang et al., 
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2014), which is in agreement with our results. Very few studies have been conducted on M-
TCS toxicity to aquatic organisms but a 72 hours bioassay on the algae Scenedesmus 
subspicatus reported an EC50 on growth rate at 170 µg/L (Batscher, 2006b) and also, a 48 
hours bioassay on Daphnia magna immobilization, reported a NOEC of 180 µg/L (Batscher, 
2006a). In comparison with our results on sea urchin, the larval length endpoint used 
appears to be more sensitive. 
In general, our results are in agreement with other previous studies. As reviewed by 
Brausch and Rand, 2011, short-term exposure assays with disinfectants on different 
species have revealed to be more toxic to invertebrates than fish. Furthermore, among other 
properties, TCS and M-TCS both show potential to adsorb to the sediment which could be 
a concerning fact since it can be an indicative of direct exposure to benthic organisms as is 
the case for the sea urchin (Orvos et al., 2002). Our study contributed to understand how 
the presence of the metabolite of this disinfectant can adversely affect the organisms, and 
although it was not as toxic as TCS for the fish, M-TCS was more toxic to the sea urchin 
than the parental compound, inhibiting the larval length. The impact on larval length could 
be an indication of an alteration on the normal development of the invertebrate and possibly 
reducing their mobility and potential for survival. Hence, long-term exposure studies should 
be conducted on this subject to better understand the possible impact of these chemicals 
on sea urchin and perhaps other invertebrate phyla. 
 PFAAs exhibited a low toxicity to zebrafish embryo assays, being less toxic than 
PFOS. Our findings are in agreement with the limited studies available in literature where a 
low toxicity was also reported (Hagenaars et al., 2011; Ding et al., 2013; Ulhaq et al., 
2013a). Nevertheless, there is some inconsistency in the true NOEC of PFOS on zebrafish 
in the literature, e.g. Huang et al. (2010) reported an LC50 at 120 hpf of 2.20 mg/L, Zheng 
et al. (2012) reported an LC50 at 72 hpf of 68 mg/L, and also, Shi et al. (2008) reported 
significant effects on zebrafish only after 84 hpf, detecting differences in the hatching rate 
at 3 mg/L and abnormalities in all embryos at 132 hpf for the concentration of 1 mg/L. In our 
assay, no significant differences were detected before the 80 hpf as in Shi et al. (2008), but 
in 144 hpf observation, all embryos were dead in the 10000 µg/L concentration (Figure 48). 
No significant differences were detected in the hatching rate but apart from the 100 µg/L 
concentration, it is possible to observe a decrease on embryos hatching, when compared 
to controls (Figure 50). PFOS development toxicity to aquatic organisms is described to be 
in the range of 1 – 100 mg/L, which validates our data (Giesy et al., 2010). Furthermore, on 
a subcellular level, Shi et al., 2010 reported an effect of PFOS on hypothalamus-pituitary-
thyroid axis’ hormones of zebrafish embryos.  
 PFOA showed no significant effects (p<0.05) for any of the endpoints at the 
concentrations tested (Table 3). Some of the studies conducted in the zebrafish confirm our 
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data by reporting an EC50 at 72 hpf of 200 mg/L (Zhen et al., 2012) and Hagenaars et al., 
reported and EC50 of 100 mg/L at 120 hpf. Both studies report effects at concentrations 
above the levels tested. It is clear that low doses of PFOA do not cause phenotypic 
alterations on embryos, however, PFOA ability to induce endocrine disruption on zebrafish 
has been reported. Recently, Du et al., 2013 reported that in a short-term assay, PFOA 
increased the expression levels of several genes in the signaling pathway of estrogen 
receptors, early thyroid development and steroid synthesis genes on zebrafish.  
Comparing these two PFAAs, it is possible to conclude that zebrafish was more 
sensitive to PFOS than PFOA. This fact supports the idea of the functional group being 
important on the PFAAs toxicity (Zheng et al., 2012; Ulhaq et al., 2013a,b). 
Exposure of zebrafish embryos to PFBS and PFBA did not induce any significant 
effects (p>0.05) for any of the endpoints considered (Table 4 and 5, respectively). Few 
toxicity studies have been conducted on these two chemicals but limit data indicates that 
PFBS appears to be more toxic than PFBA, most likely due to the presence of a sulphonic 
functional group, as is the case for its homologue, PFOS (Hagenaars et al., 2011; Ulhaq et 
al., 2013a). However, these studies were conducted with a concentration range much 
higher than the one used in our study. Besides the functional group, the chain length 
appears to be a possible explanation for PFOS greater toxicity in comparison with its 
substitute (Hagenaars et al., 2011; Ulhaq et al., 2013a,b).  
 In the present study, PFDA did not affect zebrafish development to the same extent 
as PFOS, but induced an increased number of abnormalities on embryos, causing spinal 
curvature (Figure 62 A). Consequently, increased the number of total abnormalities (Figure 
65 A) though it was not significant when compared with the solvent control. However, Ulhaq 
et al., 2013a observed frequently spinal curvature on zebrafish exposed to PFDA, reporting 
an EC50 of 5 mg/L at 144 hpf and so, though our results did not show such high toxicity, 
could still be an indication of PFDA toxicity on the embryos. As a long-chained perfluorinated 
compound (C10) it was expected to be more toxic than the shorter-chain length PFAAs 
(PFBS and PFBA). Our results show significant effects for the highest concentration but 
only at 144 hpf and only when compared with water control. This could be due to the 
presence of chorion which may protect the embryos until hatching. Few studies have been 
conducted on the toxicity of this chemical (Ding et al., 2012; Ulhaq et al., 2013a); one study 
reported that PFDA had immunomodulatory effects on rats (Nelson et al., 1992) but there 
is a serious lack on PFDA toxicity assessment to aquatic organisms, especially in marine 
species.  
 PFUnA was the second more lethal PFAA to zebrafish but induced toxicity in earlier 
stages of the embryo development. At 24 hpf, PFUnA induced early chorion softening of 
the fish on the 10000 µg/L concentration causing almost 35% of embryos hatching (Figure 
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69 A). Consequently, a decrease on hatching rate at 80 hpf in the same concentration was 
observed (Figue 69 B). Natural chorion softening in zebrafish is usually due to proteolytic 
enzymes’ digestion of the chorion which are secreted by the embryo during pre-hatching 
stages (Kim et al., 2006). A possible explanation for this results could be that PFUnA’ 
presence induced the embryo to secrete this enzymes, anticipating the natural process of 
hatching, or even, the compound itself could have digested the chorion from outside. This 
effect could adversely affect the embryo on the wild-life since the chorion could no longer 
offer protection, inducing high embryo mortality. 
Unlike the PFOS and PFDA, this compound affected the embryos before 80 hpf, 
since the mortality increase occurred right after the 32 hpf observation, reaching up to 80% 
of embryos’ mortality at the end of the assay (Figure 67). This fact could be associated with 
the lack of protection from the chorion, being directly exposed to the chemical, inducing 
toxicity. Furthermore, at 144 hpf PFUnA significantly induced an increase on tail 
abnormalities on the remaining embryos in the higher concentration (Figure 72 A). Very few 
studies have been conducted on aquatic organisms for addressing PFUnA toxicity (e.g. 
Ding et al., 2012), however, several studies were conducted on PFUnA occurrence and 
distribution on biota (Houde et al., 2011; Lindstrom et al., 2011; Hong et al., 2014). Due to 
its long-length carbon chain (C11), PFUnA have propensity to accumulate on organisms 
and though it is not find in great concentrations on surface waters, has been detected in 
concentrations up to 201 ng/g on birds’ egg yolks, being the most dominant compound in 
the study (Yoo et al., 2008). Furthermore, its ubiquitous presence is concerning. PFUnA 
was the dominant perfluorocarboxilic acid found in Canadian artic species liver. 
Concentrations up to 68 ng/g were detected on polar bears (Martin et al., 2004). 
 Concerning sea urchin bioassay, a similar response in the tested PFAAs was 
observed. In the larval length endpoint the higher concentration tested (1000 µg/L) was 
significantly different for all the perfluorinated compounds when compared to the controls 
apart from (Figure 58 A). Among PFAAs, PFOA inhibited larvae growth the most (Figure 56 
A). Regarding the percentage of larvae abnormalities, no significant differences were 
observed after 48 h for any of the PFAAs.  
In PFOS, the 2.56 µg/L treatment also showed a significant effect on larval length, 
though at higher concentrations no effect was observed, except for the 1000 µg/L 
concentration (Figure 55 A). Other studies conducted on this subject reported effects only 
at higher concentrations. A study reported a LOEC at 2 mg/L for growth inhibition of P. 
lividus (Mhadhbi et al., 2012) while another study reported significant differences on larval 
malformations for organisms exposed to 1 mg/L. In our study, the percentage of larval 
abnormalities was not significantly different for any of the concentrations tested, however, 
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for the 1000 µg/L concentration there is a clear increase in comparison with the controls 
(Figure 55 B) which could confirm PFOS toxicity to larvae.  
  For PFOA, the larvae length from the 40 and 100 µg/L concentrations were also 
significantly affected (Figure 56 A). Mhadhbi et al. (2012) reported an LOEC of 20 mg/L for 
growth inhibition of P. lividus but in our study, 0.04, 0.1 and 1 mg/L concentrations affected 
significantly the larval length, which means that the sea urchin larvae were more sensitive 
to PFOA in our assay. One possible explanation could be the fact that a solvent to deliver 
the PFOA was not used in Mhadhbi et al. (2012) which could impact the chemical solubility 
in water. In our study, PFOA did not induce significant abnormalities on larvae for any of 
the concentrations tested (Figure 56 B). In fact, very few studies were conducted on marine 
invertebrates and information on this subjected is needed. 
 PFBS inhibited larval growth, but only for the higher concentration was a significant 
decreased in comparison with the control groups. Also, the 6.4 µg/L treatment induced larval 
length increase (Figure 57 A). Other studies reported stimulation of larval development 
when exposed to other PFAAs (Anselmo et al., 2011). Thought it was not detected any 
significant differences on abnormalities percentage it is possible to observe an increase on 
abnormalities for higher concentrations, which could be indicative of possible toxicity for 
long-term exposures. For PFBA, the 100 µg/L concentration was the only concentration 
significantly different, but only differed from the 2.56, 400 and 1000 µg/L concentrations, 
showing a stimulation of the larvae development for this concentration (Figure 58 A). In the 
sea urchin bioassay, the short-chained PFBS seemed to be in the toxicity range of the long-
chained compounds PFOS and PFOA. To our knowledge no other study was conducted on 
PFBS and PFBA on sea urchin and so, more studies on this subject should be considered 
in order to improve knowledge on possible impact on marine organisms.  
  PFDA, significantly inhibited larval length at 1000 µg/L in comparison to controls, but 
no significant differences were reported on larvae abnormalities percentage (Figure 66 A, 
B). Similarly, PFUnA also did not induce any abnormalities in comparison with controls. As 
mentioned earlier, the highest concentration inhibited larvae growth but contrarily, the 2.56 
µg/L concentration stimulated larval length as in PFBS assay (Figure 75 A, B).  
 Overall, our study encompassed toxicological information on two different classes 
of chemicals with environmental relevance. Our results show that the disinfectant and its 
byproduct were more toxic to both organisms than PFAAs, whereas PFOS and PFUnA were 
the most lethal to zebrafish. This could be explained by the fact that triclosan is conceived 
to act on microorganisms, contrarily to the perfluorinated compounds. Moreover, in 
zebrafish bioassay, mortality rate was the endpoint with more significant differences for the 
tested compounds. As for the sea urchin assay, the larval length was significantly affected 
for all the tested compounds in this study. For most of PFAAs as for M-TCS, this was a first 
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approach and our data reveals a higher sensitivity of this endpoint for these chemicals as 
also reported in Ribeiro et al. (2015).  
Most of the concentrations tested were above the ones that are reported in the 
environment (Table 8). However, PFBS stimulated larvae development at 6.4 µg/L, which 
is within the concentration range detected in the environment (Table 8). Furthermore, PFOS 
and PFOA exposure to sea urchin larvae showed a significant impact on larvae length at 
environmental relevant concentrations (2.56 µg/L and 40 µg/L, respectively). Although 
some of the concentrations above did not affect the larvae development significantly, it is 
certainly warning and further investigation should be conducted. Furthermore, all PFAAs 
(except PFBA) induce larvae development delay at 1000 µg/L and previous studies reported 
accidental PFAAs releases reaching up to 17000 µg/L concentrations of total PFAAs 
(Moody et al., 2002). Moreover, it is important to highlight that M-TCS inhibited larvae length 
at very low concentrations, and even though it does not reach such values on surface 
waters, its parental compound is detected at concentrations much higher than 1 µg/L (Table 
8).  
 
Table 8 – Comparison of the LOEC values reported on this study and maximal concentrations on surface 
waters reported on literature. 
 
It would be interesting to understand PFAAs toxicity at a biochemical/molecular level 
in order to provide a more accurate prediction on the biochemical effects on organisms. 
Some studies were conducted on that subject (e.g. Shi and Zhou, 2010). Furthermore, it 
will be important to complement the data obtained here with chronic long-term assays as 
we cannot discard the possibility of chronic effect due to life-cycle exposure. 
 
 
 LOEC  
(D. rerio) 
LOEC  
(P. lividus) 
Maximal  
concentrations 
Literature 
TCS 400 µg/L 100 µg/L 22 µg/L Agüera et al., 2003 
M-TCS 400 µg/L 1.024 µg/L 0.19 µg/L Pintado-Herrera et 
al., 2014 
PFOS 10000 µg/L 2.56 µg/L 21.3 µg/L Zhou et al., 2013 
PFOA >10000 µg/L 40 µg/L 67 µg/L Nakayama et al. 
2004 
PFBS >10000 µg/L 6.4  µg/L 15.3  µg/L Zhou et al., 2013 
PFBA >10000 µg/L >1000 µg/L 47.8 µg/L Zhou et al., 2013 
PFDA >10000 µg/L 1000  µg/L 0.16 µg/L Knowick et al., 2008 
PFUnA 10000 µg/L 2.56  µg/L 0.00352 µg/L Naile et al., 2010 
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5. Conclusion and Future perspectives 
 
 Our work contributed for a better understanding on the ecotoxicological risk of 
several emerging contaminants. The compounds exhibiting higher toxicity were TCS in the 
zebrafish embryos bioassay and M-TCS in the sea urchin larvae bioassay. The PFAAs 
tested exhibited low toxicity for zebrafish, however, in the sea urchin bioassay, some PFAAs 
affected the embryo development at concentrations of environmental relevance. The sea 
urchin larval length has proved to be a very sensitive endpoint for ecotoxicological studies, 
as reported in the literature, being recognized by the responsible entities as the OECD and 
EPA.  
 The toxicological information of some of these chemicals on both organisms is new 
and so, it is important to carry on the studies on this subject and probably involve long-term 
exposure to understand the impact of these compounds in full life-cycle tests. For a more 
thorough risk assessment it would also be interesting to expose the embryos to PFAAs in 
mixture since it is known that in the environment, combined exposure are usually common. 
Furthermore it would also be important to expose sea urchin larvae to lower concentrations 
of M-TCS to refine NOEC values. 
As a follow up of this study it will be relevant to carry biochemical and molecular 
studies to understand potential effects at the subcellular level and the impacted pathways. 
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